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Abstract
M13 filamentous bacteriophage has been used as a biotemplate for the nucle-
ation of materials. Phage is an ideal and diverse scaffold with its large aspect ratio
and ability to display biomolecules to bind a range of targets. To form more complex
patterned materials, interactions between the phage must be specific and reliable.
We develop a phage labeling method using sortase enzymes to create multi-phage
nanostructures.
We exploit two sortases and functionalize the N-termini of the pIII, pIX, and
pVIII proteins with small and large moieties. For the pVIII, we show a 100 fold
improvement in display of GFP molecules on the phage surface. Taking advantage
of orthogonal sortases, we simultaneously label two capsid proteins on a single phage
particle. Using these N-terminal labeling techniques, we demonstrate fluorescent
staining of cells and construct a lampbrush phage structure linking the pIII of one
phage to the pVIII of another using a biotin-streptavidin linkage.
To further expand our labeling repertoire, C-terminal sortase labeling of phage
was pursued. To achieve this goal, we transfer a loop structure from cholera toxin
to pIII and label it with a fluorophore and a multi-domain protein. With this archi-
tecture, we form end-to-end dimers using sortase to conjugate the loop structure to
phage containing the nucleophile motif. Lastly, we investigate DNA hybridization as
a method for crosslinking phage. Using sortase, we label the pVIII on two sets of
phage: one with ssDNA and the other with a complementary DNA oligonucleotide.
We anneal these phages together and observe phage networks that are dispersed by
heat and reform upon cooling.
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Chapter 1
Background and Introduction
1.1 Introduction
Nature has developed a range of systems to address an array of functions
such as light harvesting in plants or the formation of silk fibers in spiders. These
systems have been honed over time and provide insight for engineering design in the
recapitulation of these functions. From this inspiration, biomimetic approaches have
been pursued such as those in the study of the mollusk shell. The combination of
the strength, stiffness, and toughness from the nacre structure in mollusk shells has
been used as guides for new materials [1]. This precisely ordered hybrid composite
consisting of an organic matrix and CaCO3 generates the ability for the shell to
dissipate and absorb energy effectively before failure [2]. Researchers have searched
for assembly and fabrication methods to mimic this structure and generate its energy
dissipation properties [3].
In addition to these biomimetic approaches, biological systems can be engi-
neered to introduce new functionalities or harness an innate one. The self-assembly
of biomolecules such as peptides [4], viruses [5–8], and DNA [9, 10] have been investi-
gated for the fabrication of nanoscale structures. DNA origami, which uses DNA as
a structural material, is an emerging field of research in nanomaterials and devices
[11, 12]. In this technology, connections are made using base pair matching to create
complex DNA patterns and structures (Fig. 1.1) [13]. These DNA structures have
nanometer features and can serve as chemical and biological sensors programmed
to change conformation in response to stimuli such as pH [14]. The function and
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complexity of these DNA structures are growing as seen in the creation of a DNA
nanorobot [15]. This robot consisted of a DNA scaffold carrying a molecular pay-
load and DNA switches that unlocked the structure in the presence of specific cells
to initiate delivery of cargo illustrating how DNA can function as a structural and
functional material.
In addition to scaffolds, biological systems supply enzymatic tools common-
place to biological research. HindII was the first characterized DNA restriction en-
zyme, purified from Hemophilius influenzae bacteria, and was found to cut a specific
6bp double-stranded DNA sequence [16]. Since that time, numerous restriction en-
zymes have been characterized and are standard tools used for molecular cloning [17].
At the protein level, the biotin ligase BirA from Escherichia coli (E. coli) attaches
a biotin group to a specific substrate peptide in the presence of ATP [18]. This en-
zyme is a common experimental tool for the biotinylation of purified or intracellular
proteins [19, 20].
In this work, we harness elements from two biological systems: the M13 bac-
teriophage scaffold and the enzymatic labeling of sortase A enzymes. Merging these
systems, we generate multi-phage scaffolds, which can serve as the basis for com-
plex patterned materials. In this chapter, we provide background on both of these
biological systems.
1.2 M13 bacteriophage
M13 bacteriophage is part of the Ff filamentous bacteriophage family. This
family infects E. coli and uses the host to assemble progeny phage without lysing its
host. The M13 phage has a cylindrical shape with a length of 880nm and diameter
of 6nm (Fig. 1.2a). The bacteriophage capsid is composed of five proteins (pIII, pVI,
pVII, pVIII, and pIX) to encapsulate a single stranded genome. At one end, there
2
are ∼5 copies of pIX and pVII, which form a complex to start the assembly of the
viral capsid [21]. At the other end, there are ∼5 copies of pVI and pIII, which are
responsible for infection of the bacteria [21]. The body of the phage is composed of
2700 copies of pVIII and represents 98% of the mass of the phage.
The genome of phage can be manipulated with standard molecular biology
techniques to display polypeptides as fusions to the capsid proteins. The connection
between the phenotype (the displayed capsid proteins) and the phage genome make
the virion a valuable screening tool. In 1985, George Smith introduced phage display
to screen peptide libraries on the pIII [22]. In the process (Fig. 1.2b), the phage
library is incubated with a target. Unbound phage are washed away and the bound
phage are eluted and collected. These phage are amplified and the genomes of the
phage are sequenced. With the amplified phage, the process is repeated with the
enriched phage population to find phage with the strongest binding properties and
a consensus sequence. The pIII is the most common capsid protein used in phage
display, but peptide libraries have been expressed on other capsid proteins including
pVIII [23].
A second display method, called phagemid display, is used to screen libraries
of larger moieties such as single chain antibodies [24]. In phagemid display, a library
of inducible plasmids that contain a modified version of a phage capsid protein is
transformed into bacteria. The plasmids contain an origin of replication and packag-
ing signal to form a single stranded DNA (ssDNA) version, which can be packaged
into assembling phage. The transformed bacteria are infected with a helper phage,
which generates the rest of the phage capsid proteins. When the infected bacteria are
induced, the capsid protein from the helper phage and the modified version from the
phagemid are incorporated into assembling capsids creating hybrid virions. Because
every copy of the incorporated capsid protein does not need to contain the modifica-
tion, the phagemid technique can accommodate larger fusions. However, in order to
3
Figure 1.1: Patterns generated using DNA origami. Atomic force microscopy
images of DNA structures in the shape of a rectangle, star, disc with three holes,
triangle with rectangular domains, and triangle with trapezoidal domains are shown
(adapted from [13]). The images in the top row are the same size, 165nm by 165nm.
The bottom row scale bars are 1µm for the rectangle and 100nm for the other images.
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maintain the connection between the phenotype and genotype for screening libraries,
the packaging signal of the helper phage genome is impaired such that the single
stranded version of the phagemid is given presence to package inside the assembling
viral capsids.
Using either peptide or antibody libraries, biomolecules of interest can be
identified that bind a desired target such as proteins, cell lines, and inorganics [25–
27]. For inorganics, the surface area to volume ratio of M13 bacteriophage allows for
efficient nucleation of nanoparticles in a small volume but still exposing a large surface
area. Using a pVIII peptide library, an 8-mer amino acid sequence was identified
that bound gold nanoparticles. Phage displaying this gold binding peptide sequence
was used to form gold nanowires [28]. In addition to material applications, M13
bacteriophage has been used as a scaffold in biomedical applications such as molecular
imaging [29, 30] and gene and drug delivery [31, 32].
Although there are limitations to the size of the fusions made with the capsid
proteins [33, 34], the phage can serve as a scaffold for the display of rationally designed
peptides. Four glutamic acid residues, which are negatively charged at neutral pH,
were added onto the N-terminus of pVIII to create a construct that nucleates metallic
materials through electrostatic interactions [35]. This phage has been used to nucleate
inorganics such as iron phosphate, silver, and cobalt oxide (Fig. 1.3) [35–37]. Phage
modified using a selection based or a rational design approach has been used as a
material scaffold to form battery, solar cell, and photocatalyst devices [35, 38, 39].
In addition to genetic approaches of display, phage has been used as a scaffold
for chemical modification [40]. These strategies include the incorporation of reactive
unnatural amino acids such as selenocysteine [41] or azidohomoalanine [42]. Natural
amino acids such as cysteines, arginines, lysines, and tryptophans may function as
targets for chemical modification as well [40]. These chemistries often lack speci-
ficity to a single capsid protein, which limits their utility in making phage to phage
5
6nm
880nm
a
b
Figure 1.2: M13 bacteriophage structure and phage display. M13 bacterio-
phage is cylindrical and consists of five capsid proteins (pIII, pVI, pVII, pVIII, and
pIX) encasing a single stranded genome (a). Schematic representation of the phage
display process where peptides are identified from libraries that bind a desired target
(b).
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interactions between specific capsid proteins, which is necessary for controlling the
orientation of phage.
1.3 Sortase enzymes
Sortase A enzymes are bacterial proteins that are used to affix peptides and
proteins to the cell wall [43]. These sortase enzymes recognize a peptide motif which
acts as a substrate for the enzyme forming an intermediate that is resolved by a
nucelophile motif. In this work, two sortases are discussed: Sortase A from Staphylo-
coccus aureus (SrtAaureus) and Streptococcus pyogenes (SrtApyogenes). These sortases
recognize an LPXTG and LPXTA motif, respectively [44, 45]. The enzymes cleave
after the threonine forming a thioester linkage between the carboxyl end of the thre-
onine and the sulfhydryl group on the sortase [45] (Fig. 1.4). This acyl-enzyme
intermediate is resolved by the amino group on the end of an oligoglycine or oligoala-
nine motif, respectively.
Sortase enzymes have been developed as a tool for protein labeling [46]. The
sortase chemistry offers advantages over other labeling chemistries. For labeling pro-
teins, it is specific as the motifs for labeling are not common. Different sortases can
orthogonally label a mixture of proteins or multiple locations on a single protein [47].
With this labeling method, proteins and cells have been conjugated with a range of
substrates including biotins, fluorophores, lipids, and proteins [48–50].
Recently, this labeling chemistry has been used to study the trafficking of
cholera toxin [48]. The catalytic subunit of the toxin was engineered to include the
substrate motif and labeled with a biotinylated reporter peptide that is glycosy-
lated upon reaching the endoplasmic reticulum (ER). The biotin group provides a
mechanism for detection of the subunit by immunoblot. Using this construct, the
trafficking of cholera toxin to the ER was confirmed and quantified. Additionally,
7
Figure 1.3: Biotemplation of M13 bacteriophage. M13 bacteriophage has been
used as a biotemplate facilitating the synthesis of nanowires. A visual representation
of this process is shown (top panel) and has been demonstrated for Co3O4 nanowires
for use in lithium ion battery electrodes (bottom panels) [35].
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using sortase, the catalytic subunit of diphtheria was connected to cholera toxin to
generate a lethal construct that undergoes the trafficking of cholera toxin. Using this
construct, Guimaraes et al. were able to perform a genetic screen and identify genes
critical to the trafficking of cholera toxin.
1.4 Scope of work
Although M13 bacteriophage has been used to construct devices through the
process of biotemplating, there is a limit to what can be achieved with current tech-
niques for connecting and ordering phage. To build more complex scaffolds, the
interactions between the phage must be reliable and specific.
In this dissertation, we develop the sortase labeling method on the M13 bacte-
riophage platform and create a variety of connected phage structures. In Chapter 2,
we engineer phage to participate in sortase-mediated reactions and install biotinylated
peptides and GFP molecules on the pIII, pIX, and pVIII capsid proteins using either
SrtAaureus or SrtApyogenes. We quantify the labeling and show a significant improve-
ment over phagemid display of large proteins for the pVIII. Using this conjugation
method, we show the ability to fluorescently stain specific cells using phage labeled
with a fluorophore and a targeted antibody. Using streptavidin and biotin groups
placed on the phage surface by sortase, we generate the lampbrush phage structure
by connecting the head of one phage to the body of another.
In Chapter 3, we display the SrtAaureus substrate motif by installing a loop
structure from cholera toxin onto pIII. We demonstrate that the loop can be labeled
with a fluorophore and a multi-domain protein by SrtAaureus. With this architecture
and using sortase, we fuse the sortase substrate motif of one phage to the nucleophile
motif on the pIII of another phage forming end-to-end structures. In Chapter 4,
we investigate the formation of recyclable phage networks. We build such networks
9
Figure 1.4: C- and N-terminal sortase-mediated labeling. C- and N-terminal
labeling using sortase A from Staphylococcus aureus (SrtAaureus). This figure is taken
from [51].
10
through the installation of complementary strands of DNA on two phage and anneal
the phage together by DNA hybridization. Once connected, we demonstrate that the
networks are dispersed by heating and reform upon cooling.
11
Chapter 2
Sortase-mediated labeling of M13
bacteriophage
2.1 Introduction
This chapter has been adapted from [52].
M13 bacteriophage has a cylindrical shape with a length of 880nm and a
diameter of 6nm. It encapsulates a single-strand genome that encodes five different
capsid proteins (Fig. 2.1). The body of the phage is composed of 2700 copies of
pVIII, the major capsid protein. At one end of the virus, there are ∼5 copies of both
pIII and pVI proteins, and at the other end there are ∼5 copies of both pVII and
pIX proteins [53].
The capsid proteins of M13 bacteriophage have been used to express combi-
natorial peptide libraries or protein variants (ranging from single domains to anti-
bodies) to screen for target ligands in a process known as phage display [54]. This
technique has enabled not only identification of peptides with affinity for biological
targets such as proteins, cells, and tissues [55–58], but also allowed the identification
of biomolecules that bind inorganics [27, 59]. These molecules, when expressed on
the M13 capsid proteins, can serve as scaffolds for nanowires, structures, and devices
[5, 6, 35, 38, 39].
Functionalization of a virion capsid such as M13 is currently accomplished
using chemical and/or genetic approaches [40, 60]. However both strategies have lim-
itations. Chemical conjugations are convenient and versatile, but they label motifs
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found on multiple M13 capsid proteins and oftentimes require non-physiological pH
and reducing conditions that compromise the activity of the molecule that is being
attached or of the moieties already displayed on other capsid proteins [40]. Genetic
engineering of phage allows the encoded protein/peptide to be displayed precisely
[36, 38], but it has intrinsic restrictions. Two classes of vectors are available for ge-
netic phage display: phagemid and phage. A phagemid allows expression of large
fusions with any of the five M13 phage capsid proteins, but these fusions are incor-
porated at low efficiency [61–65]. In a phage vector, the M13 bacteriophage genome
is modified directly. As a result, every copy of the recombinant capsid protein in-
corporated into the virus displays the modified protein. However, this strategy does
not support display of large moieties [66–68]. pVIII allows the display of a larger
number of recombinant molecules per phage particle, but it also has the strictest size
limitation in phage vector display. pVIII peptide libraries are mostly limited to sizes
of up to 10 amino acids, as phage with longer insertions rarely assemble [33, 34].
Insertions of 6-20 amino acids onto pVIII are possible using phagemid, but their dis-
play is inefficient with less than 25% of the copies of pVIII containing the desired
fusion product [64]. Incorporation of proteins is even less efficient on pVIII: a 23kDa
protein is displayed, on average, on less than a single copy of the pVIII fusion per
phage particle using a phagemid vector [62]. Phage display methods on the pVIII
have been able to increase the binding affinity of phage displaying a moiety [67], but
the displayed copy number of the moiety has not been determined. Large moieties
of at least 23kDa have been genetically fused to all four minor capsid proteins using
a phagemid vector [66, 69, 70], but only pIII has been extensively used in the phage
vector system [71]. However, viability of the resultant phage fusions does not guar-
antee that the recombinant peptide/protein of interest displays its native structure.
Both the environment where phage assembles and the phage coat protein to which
the protein of interest is fused may interfere with proper folding [72]. This is par-
13
Figure 2.1: M13 bacteriophage structure. M13 bacteriophage is composed of five
capsid proteins. pVIII is the major capsid protein with ∼2700 copies in each phage
particle. The pVII (light blue) and pIX (blue) are located at one end and start the
assembly process, while pIII (green) and pVI (red) are at the other end and cap the
phage. Note: the image is not to scale.
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ticularly critical for enzymes and antibodies, as they might not be functional when
incorporated into the phage structure.
To expand the versatility of M13 as a display platform, we devised a strategy
based on sortase-mediated chemo-enzymatic reactions to covalently attach a variety
of moieties to the N-terminus of pIII, pIX, and pVIII. We obtained a vast improve-
ment over the published data in the copy number of displayed peptides and proteins,
particularly on pVIII.
Sortase A enzymes allow modification of proteins by enzymatic ligation with a
wide range of functional groups (including biotin, fluorophores, and other proteins) at
the C-terminus, N-terminus, or at both termini of the protein of interest [46–50]. The
widely used sortase A from Staphylococcus aureus (SrtAaureus) recognizes substrates
that contain an LPXTG sequence [44, 51, 73], whereas sortase A from Streptococcus
pyogenes (SrtApyogenes) recognizes substrates with an LPXTA motif [45, 47]. The sor-
tase enzymes cleave between the threonine and glycine or alanine residue, respectively,
to yield a covalent acyl-enzyme intermediate that is resolved by nucleophilic attack
of a suitably exposed amine, namely oligoglycine or oligoalanine-containing peptides
[45] in the case of SrtAaureus or SrtApyogenes, respectively (Fig. 2.2). Using these
two orthogonal sortase A enzymes [47], we established conditions to site-specifically
attach two different moieties onto two capsid proteins in a single phage particle.
The sortase labeling method has several advantages over genetic and chemical
methods. First, the reaction is site-specific, as none of the coat proteins naturally
display the required motifs to participate in sortase-mediated reactions. Second,
these motifs are small and, therefore, can be easily inserted into the phage genome,
maximizing the number of potential attachment sites. Third, a protein to be displayed
on phage by means of sortase can be properly folded separate from the assembly of
phage. The site-specific nature of the reaction fixes the orientation of the displayed
protein. Fourth, the reactions are performed under physiological conditions. Fifth,
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sortase reactions afford attachment of a wide range of molecules, including those that
cannot be genetically encoded such as fluorophores and biotin.
This work establishes the component parts to build phage structures that have
new material and biological applications. We provide two examples: the creation of a
new lampbrush structure by fusing different phage particles through pIII/pVIII and
a fluorescently labeled phage containing a cell-targeting moiety to stain and to FACS
sort cells.
2.2 Results
2.2.1 N-terminal labeling of pIII using SrtAaureus
pIII has been the most extensively explored of the M13 capsid proteins in phage
display because of the flexibility and accessibility of its N-terminus [74]. Thus, we
introduced five glycines at the N-terminus of pIII (G5-pIII phage) and used SrtAaureus
to covalently attach a K(biotin)-LPETGG peptide (Fig. 2.3). The biotin moiety
allowed us to monitor the reaction by immunoblot analysis using streptavidin-HRP.
Only when sortase, G5-pIII phage, and the peptide are incubated together did we
detect a 55kDa streptavidin and anti-pIII reactive protein band (Fig. 2.3). The re-
action was specific: no other phage proteins were biotinylated. After 3hrs at 37◦C,
we achieved a yield of 68±9% labeling using 50µM peptide, 50µM SrtAaureus, 200nM
G5-pIII phage, and 10mM CaCl2. The efficiency of the reaction was calculated using
densitometric analysis of immunoblots where we compared the signal of the biotiny-
lated pIII to biotinylated GFP standards of known concentration. The amount of
biotinylated pIII was then divided by the amount of pIII molecules loaded onto the
gel, as determined by UV-vis spectrometry. The quantification was repeated for three
independent reactions with three samples analyzed for each reaction. The method of
quantification is described in further detail in the Methods section.
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Figure 2.2: Schematic of sortase-mediated labeling. Schematic representation
of the mechanism of chemo-enzymatic labeling mediated by Staphylococcus aureus
(SrtAaureus-left) or Streptococcus pyogenes (SrtApyogenes-right).
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To determine whether sortase could be exploited to attach pre-folded proteins
onto pIII, we used GFP containing an LPETG motif at its C-terminus as a substrate.
The reaction was analyzed by immunoblot using an anti-pIII antibody (Fig. 2.4).
Upon completion of the reaction, a mobility shift of pIII to the ∼80kDa region,
corresponding to the GFP-pIII fusion product, was detected. The identity of this
material was confirmed by mass spectrometry (Fig. 2.4 and Supplementary Fig.
A.1). After 3hrs at room temperature, we achieved a yield of 56±2% labeling using
20µM GFP-LPETG, 50µM SrtAaureus, 200nM G5-pIII phage, and 10mM CaCl2. The
reaction was quantified by densitometry comparing the signal of pIII-GFP to the
signal of the intact pIII input loaded into the reaction.
2.2.2 N-terminal labeling of pIX using SrtAaureus
Because the C-terminus of pIX is buried in the phage structure and therefore
unavailable for labeling [75], we attempted to label its N-terminus. However, this
region of the protein is not as accessible as in pIII and our first attempts at labeling
a phage construct displaying five glycines at the N-terminus of pIX using sortase
failed (data not shown). To increase accessibility of the five glycines, the N-terminus
of pIX was extended with an HA tag, a useful handle for detection, as no pIX-
specific antibodies are available. This G5HA-pIX phage construct was labeled with
the K(biotin)-LPETGG peptide and the reactions were analyzed by immunoblot using
streptavidin-HRP and an anti-HA antibody. A 5kDa polypeptide, reactive with both
streptavidin and anti-HA, was seen only in the complete reaction (Fig. 2.5). We
achieved a yield of 73±2% using 50µM peptide, 50µM SrtAaureus, 200nM G5HA-pIX
phage, and 10mM CaCl2 upon incubation at 37
◦C for 3hrs. A similar efficiency was
attained when attaching GFP to pIX: 74±1% of pIX was labeled when 20µM GFP-
LPETG, 50µM SrtAaureus, 200nM G5HA-pIX phage, and 10mM CaCl2 were incubated
for 3hrs at room temperature. A 35kDa anti-HA reactive polypeptide - consistent
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Figure 2.3: pIII labeling with biotin. G5-pIII modified phage (there are five
copies of pIII/ phage particle) was incubated with SrtAaureus and K(biotin)-LPETGG
peptide for 3hrs at 37◦C. The reactions were monitored by SDS-PAGE under reducing
conditions followed by immunoblotting using streptavidin-HRP (top panel) or an anti-
pIII antibody (bottom panel). The molecular weight markers are shown on the left.
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with the molecular mass of the GFP-pIX fusion protein - was detected only in the
complete reaction and its identity was confirmed by mass spectrometry (Fig. 2.6 and
Supplementary Fig. A.2).
2.2.3 N-terminal labeling of pVIII using SrtApyogenes
In the course of phage biogenesis the N-terminus of pVIII is proteolytically
cleaved, resulting in the display of an N-terminal alanine [76]. We took advantage of
this feature and exploited SrtApyogenes to label pVIII. Also, the ability of using two
orthogonal sortase enzymes (SrtApyogenes for pVIII and SrtAaureus for pIII and pIX
labeling) would further enable dual labeling of the same phage particle.
To be used as a nucleophile in SrtApyogenes-mediated reactions, pVIII requires
display of two N-terminal alanines. Thus, the N-terminus of the mature form of
pVIII was modified to AAGGGG (A2G4-pVIII phage). The glycines were introduced
to extend the N-terminus of pVIII away from the body of the phage, thus improving
the accessibility of the Ala-Ala motif for participation in the sortase reaction. Using
SrtApyogenes and a K(biotin)-LPETAA substrate peptide, we showed robust labeling
of pVIII based on an immunoblot using streptavidin-HRP (Fig. 2.7). Only when
A2G4-pVIII phage, SrtApyogenes, and the peptide were mixed together did we detect
a biotinylated 10kDa protein, consistent with the size of pVIII. The labeling reaction
was site-specific as no other proteins can be detected in the blot. We obtained a yield
of 50±3% labeled pVIII when reactions were performed at 37◦C for 3hrs with 20µM
peptide, 50µM SrtApyogenes, and 8nM A2G4-pVIII phage. This translated to 1350±90
biotin molecules on average per phage particle.
Phage assembly limits either the size of the modifications displayed on pVIII to
a few residues when using a phage vector, or it limits the number of labels attached to
pVIII when using a phagemid vector [64]. In this context, the sortase-labeling strategy
is an obvious alternative to overcome such limitations. Using 20µM GFP containing
20
Figure 2.4: pIII labeling with GFP. G5-pIII modified phage (there are five copies
of pIII/ phage particle) was incubated with SrtAaureus and GFP-LPETG for 3hrs
at room temperature. The reactions were monitored by SDS-PAGE under reducing
conditions followed by immunoblotting with an anti-pIII antibody. The molecular
weight markers are shown on the left. The unidentified anti-pIII reactive protein
(*) is most probably a proteolytic fragment of pIII. The identity of the GFP-pIII
fusion product was determined by mass spectrometry. The amino acid sequences of
pIII and GFP are shown in blue and green, respectively. The peptides identified are
highlighted in bold. The tryptic peptide comprising the GFP C-terminus, followed
by the SrtAaureus cleavage site, fused to the N-terminal glycines of pIII is shown in
red.
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Figure 2.5: pIX labeling with biotin. G5HA-pIX modified phage (there are five
copies of pIX /phage particle) was incubated with SrtAaureus and K(biotin)-LPETGG
peptide at 37◦C for the times indicated. The reactions were monitored by SDS-PAGE
under reducing conditions followed by immunoblotting using streptavidin-HRP (top
panel) or an anti-HA antibody (bottom panel). The molecular weight markers are
shown on the left.
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Figure 2.6: pIX labeling with GFP. G5HA-pIX modified phage (there are five
copies of pIX /phage particle) was incubated with SrtAaureus and GFP-LPETG at
room temperature for the times indicated. The reactions were monitored by SDS-
PAGE under reducing conditions followed by immunoblotting using an anti-HA an-
tibody. The molecular weight markers are shown on the left. The identity of the
GFP-pIX fusion product was determined by mass spectrometry. The amino acid se-
quences of pIX and GFP are shown in blue and green, respectively. The peptides
identified are highlighted in bold. The AspN digestion-resultant peptide comprising
the GFP C-terminus, followed by the SrtAaureus cleavage site, fused to the N-terminal
glycines of pIX is shown in red.
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a LPETA motif at its C-terminus, 50µM SrtApyogenes, and 8nM A2G4-pVIII phage,
we were able to attach 91±20 GFP molecules on average per phage particle upon
incubation at 37◦C for 3hrs (Fig. 2.8). The identity of the 35kDa anti-GFP reactive
protein, consistent with the size of a GFP-pVIII fusion protein, was confirmed by
mass spectrometry (Fig. 2.8 and Supplementary Fig. A.3). As estimated by nearest
neighbor packing (described in Appendix A), a single virion can accommodate 385
copies of GFP on its surface. Thus, using the sortase-mediated reaction, we obtained
a yield of ∼25% of estimated maximum packing.
2.2.4 Building end-to-body phage structures
The ability to site-specifically label the M13 capsid proteins provides the op-
portunity to create novel multi-phage structures, which may provide scaffolds for new
materials and devices. One such structure (Fig. 2.9) relies on tight binding of the
ends of several phage particles (via either pIII or pIX) to the body of another single
phage (onto pVIII). However, direct covalent attachment between two phage proteins
is not possible using sortase as we were unable to label the C-terminus of pIII, pIX,
or pVIII (data not shown). This issue was solved by attaching streptavidin to pIII,
biotin to pVIII, and then mixing the two preparations.
Streptavidin, modified to contain a C-terminal LPETG motif in each of its
monomers, was attached to the G5-pIII phage using SrtAaureus. The samples were
boiled, loaded onto an SDS-PAGE gel, and analyzed by immunoblot using an anti-pIII
antibody. A 90kDa polypeptide, consistent with the size of pIII fused to a streptavidin
monomer, was seen only when all the reaction components were mixed together (Fig.
2.10). The streptavidin-pIII phage was purified from sortase and free streptavidin by
PEG/NaCl precipitation. Dynamic light scattering (DLS) was performed in order to
monitor dispersity and aggregation. The normalized autocorrelation function (ACF)
of streptavidin-pIII phage showed an exponential decay consistent with monodisperse
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Figure 2.7: pVIII labeling with biotin. A2G4-pVIII modified phage (there are
2700 copies of pVIII/ phage particle) was incubated with SrtApyogenes and K(biotin)-
LPETAA peptide at 37◦C for the times indicated in the figure. The reactions were
monitored by SDS-PAGE under reducing conditions followed by immunoblotting us-
ing streptavidin-HRP. The molecular weight markers are shown on the left.
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Figure 2.8: pVIII labeling with GFP. A2G4-pVIII modified phage (there are 2700
copies of pVIII/ phage particle) was incubated with SrtApyogenes and GFP-LPETA
at 37◦C for the times indicated in the figure. The reactions were monitored by SDS-
PAGE under reducing conditions followed by immunoblotting an anti-GFP antibody.
The molecular weight markers are shown on the left. The unidentified anti-GFP
reactive protein (*) is attributed to proteolyzed GFP forming an intermediate with
SrtApyogenes. The identity of the GFP-pVIII fusion product was determined by mass
spectrometry. The amino acid sequences of pVIII and GFP are shown in blue and
green, respectively. The peptides identified are highlighted in bold. The tryptic
peptide comprising the GFP C-terminus, followed by the SrtApyogenes cleavage site,
fused to the N-terminal alanines of pVIII is shown in red.
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Figure 2.9: Schematic of lampbrush phage structure. Schematic representation
of the strategy used to build a lampbrush structure. Upon labeling of the N-terminus
of pIII with streptavidin and of the N-terminus of pVIII with biotin using sortase-
mediated reactions, the phage were mixed (see Methods section for details).
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populations (Fig. 2.11a). This was confirmed by atomic force microscopy (AFM) that
showed individual virions, indicating that only a single phage particle was attached
per streptavidin tetramer (Fig. 2.12). Biotin was conjugated to pVIII using the
K(biotin)-LPETAA peptide and SrtApyogenes as described above. The biotinylated
phage was purified by PEG/NaCl precipitation to remove free peptide and the sortase-
acyl intermediate. The biotinylated phage was observed as individual phage particles
by AFM and the ACF showed an exponential decay, again indicating a monodisperse
population (Fig. 2.11a and Fig. 2.12).
The streptavidin-pIII phage and the biotin-pVIII phage were mixed at a 5:1
molar ratio and incubated at room temperature for 15min. Analysis of these sam-
ples by DLS showed an increase of the hydrodynamic diameter for the lampbrush
phage mixture (700nm) when compared to streptavidin-pIII (516nm) and biotin-
pVIII (204nm) phage preparations. When the two types of phage were mixed, the
ACF (Fig. 2.11a) shows a rising shoulder at longer relaxation times, indicating a
polydisperse population. The longer relaxation times observed in the shoulder rep-
resent structures larger than single phage. These larger structures were observed by
AFM (Fig. 2.11b). Linkages between the end of one phage and the body of another
phage were observed when streptavidin-pIII and biotin-pVIII are mixed. These link-
ages were not detected when the individual phages were visualized by AFM (Fig.
2.12).
2.2.5 Site-specific labeling of two capsid proteins in the same
phage particle
The two orthogonal sortases used to label different capsid proteins offer the
possibility to attach different moieties to the body (using SrtApyogenes) and to the end
of phage (using SrtAaureus) within the same virion. In such a strategy, either pIII
or pIX could be labeled with SrtAaureus orthogonally to the pVIII, so as a proof-of-
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Figure 2.10: pIII labeling with streptavidin. G5-pIII phage (there are five copies
of pIII/ phage particle) was incubated with SrtAaureus and streptavidin containing a
C-terminal LPETG motif in each monomer. The reactions were monitored by SDS-
PAGE under reducing conditions followed by immunoblotting using an anti-pIII anti-
body. The molecular weight markers are shown on the left. The unidentified anti-pIII
reactive protein (*) is attributed to proteolyzed pIII. The identity of the streptavidin-
pIII fusion product was determined by mass spectrometry. The amino acid sequences
of pIII and streptavidin monomer are shown in blue and green, respectively. The
peptides identified are highlighted in bold. The tryptic peptide comprising the strep-
tavidin C-terminus, followed by the SrtAaureus cleavage site, fused to the N-terminal
glycines of pIII is shown in red.
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ba
Figure 2.11: Characterization of lampbrush phage structure. Upon labeling
of the N-terminus of pIII with streptavidin and of the N-terminus of pVIII with
biotin using sortase-mediated reactions, the phage were mixed (see Methods section
for details). The resulting product was visualized by dynamic light scattering (a) and
by atomic force microscopy (b).
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concept, a phage variant that contains a double alanine at the N-terminus of pVIII
and the pentaglycine motif at the N-terminus of pIII was generated (this construct
is referred to as G5-pIII-A2-pVIII). Conditions were optimized to label each of these
proteins in a site-specific manner. Because such dual-labeled phage could be a useful
tool to sort cells by FACS (see below and Discussion section), we here provide the
proof-of-concept by labeling the body of phage with a fluorophore and the tip of
phage with a cell-targeting moiety.
pVIII was labeled with a K(TAMRA)-LPETAA peptide and purified using
PEG/NaCl precipitation to remove free peptide and sortase (Fig. 2.13a). A fluo-
rescent 10kDa protein, corresponding to pVIII, was the only polypeptide detected
in the complete reaction. This confirmed successful labeling and site-specificity of
SrtApyogenes. The pIII of this fluorescent phage was then incubated with SrtAaureus
and a 15kDa single domain antibody, VHH7, modified with a C-terminal LPETG
motif. VHH7 recognizes murine Class II MHC products (the development and ex-
pression of VHH7 will be described elsewhere). Attachment of VHH7 to pIII was
monitored by immunoblot using an anti-pIII antibody (Fig. 2.13b). Comparing the
signal intensities of VHH7-pIII 90kDa polypeptide and of pIII, we estimated that on
average 2-3 VHH7 molecules are attached per phage particle, a number similar to
what can be obtained when screening phagemid libraries of pIII fusions by panning
[77, 78].
2.2.6 Flow cytometry experiments using fluorescent phage
Fluorescent phage has been used for targeted staining in vivo [29, 79] as well
as flow cytometry experiments [80]. However, these have been performed with short
peptide phage display libraries. The ability to label phage with a large number of
fluorophores that are site-specifically attached to pVIII is a tool useful for selecting
phage of interest from phage display libraries of large moieties (such as antibodies)
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Biotin-pVIII Streptavidin-pIII
Lampbrush Phage
Figure 2.12: AFM characterization of lampbrush phage structure. Phage
with the N-terminus of pIII labeled with streptavidin and phage with the N-terminus
of pVIII conjugated to biotin were created using sortase-mediated reactions. The
phage preparations were visualized by AFM before (top right and top left panels)
and after mixing (bottom panels; see Methods section for details).
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by fluorescence. With libraries of this type, less specific labeling methods can alter
the displayed moiety. To provide proof-of-concept that fluorescent phage can be used
for this purpose, we tested the ability of the dual labeled phage - containing TAMRA
fluorophore sortagged onto pVIII and VHH7 onto pIII - to stain B cells. As a negative
control, we used a fluorescent phage containing an anti-GFP VHH attached to pIII
[81]. An average yield of 2.5 antibodies per phage virion was achieved for both VHH7
and anti-GFP VHH as determined by densitometric analysis.
Mouse lymphocytes obtained from lymph nodes were stained for B cells using a
fluorescent Pacific Blue anti-mouse B220 antibody and incubated with phage-VHH7,
phage-anti-GFP, or non-targeted phage. All phage preparations were similarly labeled
with TAMRA on pVIII. After removal of unbound materials by washing, cells were
subjected to flow cytometry (Fig. 2.14). When stained with phage-VHH7, we de-
tected an increase in cells double positive for TAMRA and the B cell marker compared
to non-specific staining with phage-anti-GFP or non-targeted phage. Staining of cells
with phage-VHH7 was vastly superior to VHH7 directly conjugated to TAMRA, as
only a few double positive cells were detected when incubated with an equivalent
amount of the latter (Fig. 2.14).
2.3 Discussion
We show that sortase-mediated reactions overcome many of the limitations of
current methods to functionalize M13 capsid proteins. The main body and both ends
of the viral capsid can be functionalized with substituents that cannot be encoded
genetically (such as biotin and fluorophores), and we can also install properly folded
and assembled proteins (such as GFP and streptavidin) in a manner that could easily
be extended to oligomeric proteins as well.
One of the major challenges has been the modification of the major capsid
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Figure 2.13: Dual labeling of phage using orthogonal SrtApyogenes and
SrtAaureus. Schematic representation of the strategy used to couple two different
moieties to two different capsid proteins (a). Labeling of pVIII with a K(TAMRA)-
LPETAA peptide mediated by SrtApyogenes was followed by labeling of pIII with a
single domain antibody directed to Class II MHC as a cell targeting moiety and
SrtAaureus (see Methods section for details). The final product was analyzed by fluo-
rescent scanning imaging to visualize labeling of pVIII, followed by immunoblotting
using an anti-pIII antibody to monitor the efficiency of labeling (b). There are five
copies of pIII/ phage particle. The asterisks indicate unidentified anti-pIII reactive
proteins, which probably correspond to proteolytic fragments of pIII.
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protein pVIII. Using sortase, labeling efficiencies were greater than those obtained
genetically (Table 2.1). In the past, biotinylated phage has been produced by display
of the biotin acceptor peptide (BAP) [82], a 15-amino acid sequence. Peptides similar
in size have been displayed at no more than 400-700 copies per phage, with the
efficiency being sequence-dependent [64]. Here we attach 1350 biotin molecules on
average per phage particle, a great improvement in the display of a small molecule.
Moreover, because the peptide substrate for sortase can be modified with peptides,
proteins, fluorophores, etc. [46–50], phage can be decorated with a wide range of
substituents. As far as display of proteins is concerned, proteins similar in size to
GFP have been incorporated at fewer than one copy per phage on pVIII using a
phagemid system [62]. Using sortase, we display ∼90 GFP molecules on average per
phage particle.
Table 2.1: Labeling efficiency for each of the phage coat proteins using
sortase.
Minor Capsid Proteins
Capsid Protein Probe Efficiency
pIII Biotin 68±9%
pIII GFP 56±2%
pIX Biotin 73±2%
pIX GFP 74±1%
Major Capsid Protein
Capsid Protein Probe Optimal Packing Copy Number/Phage
Using Sortase
Literature
pVIII Biotin 2700 1350±90 400-700
pVIII GFP 385 91±20 <1
For the pIII and pIX proteins, we show that every phage can be labeled with
multiple copies of the desired peptide/protein (Table 2.1). An advantage of using
sortase to covalently attach proteins to phage over genetically engineering pIII directly
is that it ensures display of the correct quaternary structure of the protein. This
can be inferred from our experiments using streptavidin. The mixing of two phage
particles, one containing streptavidin on pIII and the other containing biotin on pVIII
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Figure 2.14: Staining of Class II MHC+ cells using dual labeled phage.
Binding of the dual labeled phage to lymphocytic Class II MHC+ cells was observed
by flow cytometry. The Class II MHC+ enriched cell fraction of the lymph nodes of
a C57BL/6 mouse was stained for B220 together with the dual labeled phage (phage-
TAMRA-VHH7), TAMRA labeled phage (no cell targeting motif, phage-TAMRA),
or anti-Class II MHC directly conjugated to TAMRA (TAMRA-VHH7).
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results in a novel and complex phage structure. This shows that the streptavidin
structure displayed on phage remains fully active and binds biotin.
Sortase enzymes in combination with the streptavidin-biotin pair [83] or in
conjunction with click-chemistry can generate novel structures. The ability of pat-
terning and aligning materials on phage or of increasing its surface area is important
for the development of new materials. For example, the lampbrush phage structure
generated here (Fig. 2.9) may find application in light-sensitive processes where phage
branching off the stem could be functionalized to act as antennae to capture light [84].
In addition to N-terminal labeling of single capsid proteins, two capsid proteins
were labeled site-specifically on a single phage particle using two orthogonal sortases.
This could be explored for panning of antibody libraries displayed on pIII. Due to the
exquisite site-specificity of sortase, fluorescent peptides can be added to pVIII without
modification of the moiety displayed at pIII. Fluorescent labeling by other chemistries
does not easily afford such specificity, especially when displaying a large moiety, such
as an antibody fragment. The sensitivity of detection should increase when a phage
particle contains many fluorophore groups on pVIII. This is indeed what we observe
in our flow cytometry experiments, showing that this strategy greatly enhances the
sensitivity of detection. Increased sensitivity would be instrumental in the context
of a future panning strategy for detection of rare binding events, whether due to low
concentration of the target or low phage concentration.
Modification of pIII and pIX by sortase will be useful first and foremost for
material applications, where the physical properties of phage and not its utility as a
library vector are of prime concern. Fluorescent modification of pVIII is compatible
with the construction and screening of libraries created using pIII genetic fusions. In
this case, the site-specificity and yield of the sortase reaction allow the generation of
libraries that can be screened directly by fluorescence. Thus, the versatility of the
sortase-based labeling strategy described here will enable development of a wide array
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of tools, expanding the use of phage either for the creation of new materials or for
new biological applications.
2.4 Methods
Generation of M13 phage constructs
The oligonucleotides used to design the different phage constructs are com-
piled in Supplementary Table A.1. The G5-pIII phage was engineered by inserting
the G5pIIIC and G5pIIINC annealed oligonucleotides into the M13KE vector (New
England Biolabs), previously digested with EagI and Acc65I restriction enzymes.
To construct the A2G4-pVIII phage, the M13SK vector [23] was digested with PstI
and BamHI restriction enzymes and the A2G4pVIIIC and A2G4pVIIINC annealed
oligonucleotides were inserted. To engineer the G5HA-pIX construct, the 983 vector
was used (Ghosh, D. et al., unpublished). This vector was created by refactoring
the M13SK vector so the pIX and pVII genes are not overlapping. Upon digestion
of this vector with SfiI, the annealed G5HApIXC and G5HApIXNC oligonucleotides
were inserted. The G5-pIII-A2-pVIII phage construct was created using a modified
M13SK vector [23], which has a DSPHTELP sequence on pVIII and a biotin accep-
tor peptide (GLQDIFEAQKIEWHE) on pIII. Five N-terminal glycines were added
to pIII following the above strategy described for G5-pIII phage. The resultant vector
was then modified at the N-terminus of pVIII using the QuikChange II site-directed
mutagenesis kit (Stratagene) and the pVIIIAADSPH oligonucleotide pair. All the
generated phage vectors were transformed into the XL-1 Blue bacterial strain, plated
in agar top on LB agar plates containing 1mM IPTG, 40µg/mL X-Gal, and 30µg/mL
tetracycline. Plaques were selected and DNA was isolated and sequenced to check for
the insertion.
For phage amplification, the E. coli strain ER2738 (New England Biolabs)
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in LB media supplemented with 30µg/mL tetracycline, was infected with phage for
at least 12hrs at 37◦C. The cultures were centrifuged at 12000g for 20min and the
phage was precipitated from the supernatant at 4◦C with the addition of 1/5 of the
supernatant volume of 20% PEG8000/2.5M NaCl solution. Upon centrifugation at
13500g for 20min, the pellet was resuspended in 25mM Tris, 150mM NaCl, pH 7.0-
7.4 (TBS). For further purification, this resuspension was subjected to two rounds of
centrifugation/precipitation. The final phage concentration averaged between 1013-
1014 plaque forming units (pfu) per mL as determined by UV-vis spectrometry [76].
Sortase-mediated reactions
SrtApyogenes and SrtAaureus were expressed and purified as described [47, 85].
Sortase reactions were performed as indicated in the figures. A typical sortase reaction
with SrtAaureus included 200nM phage, 50µM SrtAaureus, and 50µM substrate for small
peptides or 20µM for proteins. The reactions were incubated for 3hrs at 37◦C (for
small peptides) or at room temperature (for proteins) in TBS with 10mM CaCl2.
SrtApyogenes-mediated reactions included 8nM phage, 50µM SrtApyogenes, and 20µM
substrate, incubated for 3hrs at 37◦C in TBS. Where indicated, phage was purified
by PEG 8000/NaCl precipitation after diluting the reactions with TBS such that the
substrate concentration was below 600nM.
For the flow cytometry experiments, the G5-pIII-A2-pVIII phage construct
was labeled with K(TAMRA)-LPETAA on pVIII. The resultant labeled phage was
purified by PEG8000/NaCl precipitation, resuspended in TBS, and split into three
parts. One part remained unlabeled, and the other two were labeled with either
VHH7.LPETG or anti-GFP.LPETG on pIII. As assessed by the anti-pIII antibody,
a yield of 2.5 antibody molecules per virion was achieved in both cases.
The yield of the sortase-mediated biotinylation reactions was determined using
biotinylated GFP as a standard. This was prepared labeling GFP - comprising a
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LPETG at its C-terminus - with a biotin group using SrtAaureus (GFP.LPETGGGK
(biotin)) [85]. Known amounts of the purified GFP.LPETGGGK(biotin) standard
and varying volumes of the phage labeling reactions were loaded onto the same SDS-
PAGE gel and analyzed by immunoblot using streptavidin-HRP (GE Healthcare).
The signal obtained in the phage labeling reactions was compared with the signal
derived from the GFP.LPETGGGK(biotin) calibration curve allowing us to infer the
amount of phage protein labeled in the reaction. To calculate the labeling efficiency,
the amount of labeled protein was divided by the amount of total phage protein loaded
into the gel. The phage concentration was determined by UV-vis spectrometry and
it was assumed that there were 2700 copies of pVIII, 5 copies of pIII, and 5 copies of
pIX per phage particle.
To determine the yield of GFP-pVIII phage labeling, unincorporated GFP and
sortase was removed from phage by PEG8000/NaCl precipitation. Varying volumes
of GFP-pVIII phage and known amounts of GFP were loaded onto the same SDS-
PAGE gel and analyzed by immunoblot using an anti-GFP-HRP antibody (Santa
Cruz Biotechnology). The signal of the GFP-pVIII fusion protein was compared to
the signal of the GFP calibration curve as described for the biotinylation reactions.
For GFP-pIII and GFP-pIX labeling, the signal of the fusion protein was compared
to the input amount of pIII or pIX as detected by anti-pIII (New England Biolabs) or
anti-HA (Roche) antibodies, respectively. For GFP-pIII, the input signal consisted of
only intact pIII molecules and lower molecular weight anti-pIII reactive proteins were
not included. These proteins can be attributed to proteolyzed pIII [86]. Because the
anti-pIII antibody recognizes the C-terminus of the protein, these fragments cannot
be labeled using SrtAaureus. In all cases the blots were scanned and densitometric
analysis was performed using the ImageJ program (National Institutes of Health).
The labeling yield was averaged over three independent reactions with three aliquots
from each reaction analyzed. The standard deviation of the reactions was calculated
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from the averages of the three independent reactions.
Dynamic light scattering (DLS)
DLS measurements were obtained with a Beckman Delsa-Nano C Particle
Analyzer (Beckman Coulter Inc). Phage mixtures were diluted to ∼1011pfu/mL in
1mL of water and loaded into a cuvette. Samples from each experiment were measured
in triplicate and the results were averaged by cumulant analysis. Autocorrelation
functions were used as a direct comparison of aggregation because aggregates have
a slower Brownian motion causing the signal correlation to be delayed to longer
relaxation times.
Atomic force microscopy (AFM)
Phage preparations were diluted to a concentration of ∼1011pfu/mL, and
100µL of this mixture were deposited on a freshly cleaved mica disc. AFM im-
ages were taken on a Nanoscope IV (Digital Instruments) in air using tapping mode.
The tips had spring constants of 20-100N/m driven near their resonant frequency of
200-400kHz (MikroMasch). Scan rates were approximately 1Hz. Images were leveled
using a first-order plane fit to remove sample tilt.
Flow cytometry analysis
C57BL/6 mice were purchased from Jackson Labs. Animals were housed at
the Whitehead Institute for Biomedical Research and were maintained according to
guidelines approved by the Massachusetts Institute of Technology (MIT) Committee
on Animal Care.
Lymph nodes were isolated from 6-8 week old C57BL/6 mice and crushed
through a 40µM cell strainer. Cells were washed once with PBS, resuspended at
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2x107 cells per mL, aliquoted at ∼1x106 cells per sample, and incubated with staining
agents in 5% milk in PBS for 1hr at room temperature. 1011 VHH7 molecules and 1011
anti-GFP molecules either directly conjugated to TAMRA using SrtAaureus, or cova-
lently attached to phage (5x1010 phage particles of VHH7-G5-pIII-TAMRA-A2-pVIII
or anti-GFP-G5-pIII-TAMRA-A2-pVIII, see Sortase-mediated reactions section) were
incubated with the cells. The same amount of non-targeted fluorescent phage par-
ticles (i.e., G5-pIII-TAMRA-A2-pVIII) was used as a negative control. B cells were
stained with Pacific Blue anti-mouse B220 (BD Pharmingen, clone RA3-6B2). Upon
staining, the cells were centrifuged at 170g for 5min, washed with PBS three times,
and resuspended in 500µL of PBS. Flow cytometry was performed using a FACSAria
(BD). 100,000 events were collected for each sample.
Miscellaneous
Expression and purification of GFP.LPETG.His6 and GFP.LPETA.His6, were
performed as described [47]. Identification, characterization, expression, and purifi-
cation of VHH7.LPETG.His6 will be described elsewhere. Streptavidin was cloned as
a streptavidin.LPETG.HAtag.His6 fusion protein using the template Addgene 20860
[87], and expressed as a soluble tetrameric streptavidin [87]. Purification was per-
formed following the same protocol used for GFP [47]. Sortase reactions were an-
alyzed on 4-12% Bis-Tris SDS-PAGE gels with MES running buffer except for Fig.
2.10 which was analyzed on a 12% Laemmli SDS-PAGE gel.
The K(biotin)-LPETGG, K(biotin)-LPETAA, K(TAMRA)-LPETAA, and GG-
GK(biotin) peptides were obtained from the Swanson Biotechnology Center. For mass
spectrometry, the protein bands of interest were excised, subjected to protease diges-
tion, and analyzed by electrospray ionization tandem mass spectrometry (MS/MS).
Fluorescent gel images were obtained using a variable mode imager (Typhoon 9200;
GE Healthcare).
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Chapter 3
C-terminal sortase-mediated label-
ing of M13 bacteriophage
3.1 Introduction
M13 bacteriophage is composed of five capsid proteins (pIII, pVI, pVII, pVIII,
and pIX). In the process of phage display, genetic fusions of these capsid proteins
with peptide/protein libraries have allowed for the selection of biomolecules that
bind organic [25, 26] and inorganic materials [27]. Engineered phage displaying these
selected biomolecules can form the framework for devices with applications in the
biological and material sciences [35, 38, 39].
Phage display can be achieved through two methods. The first uses phagemids
which are plasmids that encode a mutant form of a capsid protein. Helper phage
infects bacteria containing the plasmid and the replicated phage contains a mixture
of the mutant form as well as the capsid protein of the helper phage creating a
hybrid virion. The second method is phage vector display where the phage genome is
modified directly ensuring that every copy of the capsid protein is modified, but the
method has a more strict size limitation to the fusions than phagemids.
Phage display has primarily been performed on the N-termini of the capsid
proteins [71], as the C-termini of the phage capsid proteins are buried with the ex-
ception of pVI [75]. Although C-terminal display has been achieved with phagemids
[69, 70, 88, 89], the fusions have been expressed with low efficiency. For phage vec-
tor display, there have been no documented C-terminal fusion proteins. Nonetheless,
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C-terminal display is required for certain protein motifs to maintain their function
[90, 91]. The installment of a conjugation chemistry motif would allow for the display
of these moieties on the surface of phage.
Sortase A enzymes allow modification of the C-terminus of proteins through
a chemo-enzymatic reaction with a wide range of functional groups including biotin,
fluorophores, and other proteins [46, 48, 50]. Sortase A from Staphylococcus aureus
(SrtAaureus) recognizes an LPXTG substrate sequence [44]. The enzyme cleaves be-
tween the threonine and glycine forming a covalent acyl-enzyme intermediate, which
is resolved by the attack of an N-terminally exposed oligoglycine sequence.
Sortase-mediated reactions are well-suited to C-terminal labeling of capsid
proteins. First, the motif is small which makes it a candidate to be expressed in
a phage vector on the C-terminus of the proteins. Second, the labeling method is
versatile and capable of attaching both small and large moieties to the end of phage.
Third, the reaction is site specific and none of the capsid proteins naturally express
the nucelophile or substrate sequences required for a sortase reaction.
Initial attempts at C-terminal display of the sortase substrate motif were un-
successful. However, display of a C-terminus could still be achieved through a loop
architecture that can expose a C-terminus upon proteolysis and remain attached by
a disulfide bridge between two cysteine residues. The structure of the loop is impor-
tant and many of the possible sequences may not form a loop even with two cysteine
residues present. Therefore, we used inspiration from cholera toxin (Ctx), which con-
tains an accessible loop in its structure. The Ctx loop was engineered in order to
label the A1 subunit of cholera toxin with sortase by displaying the LPXTG sequence
[48].
We transplanted the sortaggable loop from the cholera toxin subunit to pIII
creating an architecture for C-terminal phage display and C-terminal sortase labeling
on phage. We demonstrate that the Ctx loop architecture can conjugate small and
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large moieties using sortase expanding the moieties that can be displayed on pIII.
With this ability, we created end-to-end dimer structures linking our loop architecture
with phage containing the sortase nucleophile motif.
3.2 Results
3.2.1 C-terminal phage vector display of the sortase sub-
strate motif
Table 3.1: Restriction enzymes used for C-terminal phage vector display
Capsid Protein Enzymes
pIII BspEI & BclI
pVI AatII & AgeI
pIX SpeI & BspHI
To test if C-terminal phage vector display was possible, we genetically fused
the sortase substrate motif to the C-terminus of the pIII, pVI, and pIX proteins. Near
the C-termini end of the genes encoding these capsid proteins, we introduced silent
mutations to insert restriction sites that cut a single time in the phage genome. The
restriction sites for each capsid protein are listed in Table 3.1. The pVII and pVIII
were not investigated as the C-termini of these proteins are less exposed than the
other capsid proteins [75]. Using the inserted restriction sites, we add an LPETGG
motif followed by an HA tag to the C-termini of the capsid proteins. The HA tag
was added in order to determine whether the C-terminus was exposed to participate
in the sortase reaction. By inserting no linker, GGGS, and (GGGS)3 upstream, we
extended and altered the flexibility of the sortase motif. For each of these insertions,
we analyzed the ligation reaction by PCR to check that a phage vector containing
the new insert was present (Fig. 3.1). In these PCR reactions, we detected a ∼500bp
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DNA species when the primers that matched the insertion were included. Despite the
confirmed presence of the inserted DNA sequence, we found no phage that contained
the desired modification.
3.2.2 Display of a sortaggable loop on pIII
We circumvented the inability to perform C-terminal display by introducing
a sortaggable loop onto pIII. Previously, a sortaggable loop had been created on
cholera toxin A1 subunit [48]. This loop contained an LPXTG recognition motif for
SrtAaureus followed by an HA tag and a trypsin cut site. The trypsin cut site was used
to open the loop to improve labeling efficiency. The HA tag was added to monitor
sortase activity as it is released by sortase in an opened loop. We engineered the
phage genome to display the loop fused to the N-terminus of pIII. Sortagging with a
GGGK(TAMRA) probe was observed only when trypsin was added to the reaction
(data not shown). However, trypsin digested pIII in addition to opening the loop.
Despite all of our attempts, we did not find a concentration of trypsin compatible
with opening the loop efficiently while simultaneously maintaining the structure of
pIII.
3.2.3 C-terminal labeling of Factor Xa loop
In order to avoid proteolysis other than opening the loop, the trypsin cut site
was modified by mutagenesis to a Factor Xa site as this protease does not digest
pIII. Using this LoopXa-pIII construct, the loop can be cleaved completely without
disrupting the pIII structure. A schematic of the labeling method is shown in Fig.
3.2.
We labeled the loop with a GGGK(TAMRA) peptide using SrtAaureus (Fig.
3.3). We analyzed the reactions by SDS-PAGE under both reducing and non-reducing
conditions followed by fluorescent imaging and Coomassie staining. We observed a
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Figure 3.1: C-terminal display on pIII, pVI, and pIX. DNA insertions en-
coding LPETGG-(HA), GGGS-LPETGG-(HA), and (GGGS)3-LPETGG-(HA) were
inserted genetically at the C-terminus of pIII, pIX, and pVI. The ligation reactions of
these inserts were analyzed by PCR using one of the insertion oligonucleotides from
the ligation and a second primer matching an unmodified part of the phage vector
oligo (see Methods for details) to determine whether the inserts had been incorporated
into the genome.
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60kDa fluorescent protein when LoopXa-pIII phage, GGGK(TAMRA), SrtAaureus,
and Factor Xa were mixed together in non-reducing conditions. The same 60kDa
polypeptide corresponds to the LoopXa-pIII protein, which was observed by Coomassie
staining (Fig. 3.3).
To demonstrate labeling with a large moiety, we labeled the loop with cholera
toxin subunit B (CtxB). The B subunit forms a 58kDa pentamer [92] and each subunit
was expressed with a G3 nucleophilic motif for SrtAaureus. In the presence of SDS and
heat, the pentamer can be converted to its monomer form. LoopXa-pIII phage was
incubated with Factor Xa, SrtAaureus, and G3-CtxB for 5hrs at room temperature. We
monitored the reactions by SDS-PAGE under reducing and non-reducing conditions
followed by immunoblot with an anti-pIII and anti-CtxB antibody (Fig. 3.4). When
phage, SrtAaureus, Factor Xa, and G3-CtxB were mixed in non-reducing conditions,
we detected a 75kDa anti-pIII and anti-CtxB reactive protein consistent with the
size of the pIII-CtxB fusion. This identity of this protein was confirmed by mass
spectrometry (Fig. 3.4 and Supplementary Fig. A.4)
3.2.4 Building of end-to-end phage structures
Phage has been used to biotemplate materials [28, 35, 36], but the ability
to control and link the virions can expand the functionality of the phage to form
patterned multi-material devices. One such pattern is the end-to-end structure where
two phage can be linked pIII to pIII. Using the loop architecture and SrtAaureus, we
formed phage to phage linkages as shown in Fig. 3.5.
In order to form these structures, we used G5-pIII phage containing the nucle-
ophile motif for SrtAaureus [52]. We incubated the LoopXa-pIII phage with SrtAaureus,
Factor Xa, and G5-pIII phage for 24hrs with 10mM CaCl2. Due to the slow diffusion
of the nucelophile and substrate in this reaction, we did not observe any linkages.
In order to improve the chances of linkages, we extended the incubation time to
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Figure 3.2: Schematic of sortagging LoopXa-pIII phage. A loop structure from
cholera toxin subunit A was fused to pIII. The loop contains the sortase substrate
motif (red), an HA tag (purple), and Factor Xa cleavage site (black). The structure
is held together by a disulfide bridge (dotted line).
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Figure 3.3: Labeling of pIII loop with TAMRA. LoopXa-pIII phage (there are
five copies of pIII /phage particle) was incubated with Factor Xa, GGGK(TAMRA),
and SrtAaureus at room temperature for 5hrs. The reactions were resolved in SDS-
PAGE under reducing and non-reducing conditions followed by fluorescent imaging
(top) and staining with Coomassie (bottom). The molecular weight markers are
shown on the left. The unidentified proteins (*) are most likely E. coli proteins from
the phage preparation.
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60hrs. After incubation, we removed sortase using PEG8000/NaCl purification and
resuspended the phage in water. We visualized the purified phage by atomic force
microscopy (AFM) (Fig. 3.6a). Linkages between the head of two phages were ob-
served in structures that measured nearly 2µm in length. We estimated that 3% of
phage visualized were in the dimer form. To determine that the linkages were the
result of sortase and not disulfide bonds formed between cysteines on two different
phage, we analyzed G5-pIII phage, LoopXa-pIII phage, G5-pIII with LoopXa-pIII
phage, LoopXa-pIII phage and SrtAaureus by AFM (Fig. 3.7). We did not observe
end-to-end interactions between phage in any of these samples.
We investigated these dimer phage structures by dynamic light scattering
(DLS) to monitor the change in particle size (Fig. 3.6b). The total population did
not show a change in hydrodynamic radius, but in the normalized autocorrelation
function (ACF), we saw a polydisperse population with a second population exhibit-
ing longer relaxation times consistent with structures larger than single phage. We
analyzed G5-pIII and LoopXa-pIII phage by DLS, and we found their ACFs exhibited
exponential decay consistent with a monodisperse population of single phage (Fig.
3.6b). To determine that the dimers were sensitive to reducing agents, we added
the reducing agent dithiothreitol (DTT) to the pIII-pIII dimer sample. By DLS,
we did not detect the population with longer relaxation time and the ACF showed
exponential decay similar to those observed for single phage (Fig. 3.6b).
3.3 Discussion
The Ctx loop provides the architecture for C-terminal phage vector display of
short peptides such as the sortase substrate motif. We demonstrate that the display
of this motif makes it possible to attach diverse moieties at the C-terminus site-
specifically. These conjugations demonstrate the versatility of installing the sortase
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Figure 3.4: Labeling of pIII loop with CtxB. LoopXa-pIII phage (there are
five copes of pIII /phage particle) was incubated with Factor Xa, G3-CtxB, and
SrtAaureus at room temperature for 5hrs. The reactions were resolved in SDS-PAGE
under reducing and non-reducing conditions followed by immunoblot with an anti-
pIII antibody and anti-CtxB antibody. The molecular weight is indicated on the
left. The unidentified anti-pIII reactive protein (*) is most probably a proteolytic
fragment of pIII. The identity of the pIII-CtxB fusion product was determined by
mass spectrometry. The amino acid sequences of the LoopXa-pIII and CtxB are
shown in blue and green respectively. The disulfide bridge in the loop is shown in
black. The peptides identified are highlighted in bold. The chymotryptic peptide
comprising the LoopXa-pIII C-terminus followed by the SrtAaureus cleavage site fused
to the N-terminal glycines of CtxB is shown in red.
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Figure 3.5: Schematic for end-to-end phage dimers. Schematic representation
of the strategy used to build end-to-end phage structures.
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Figure 3.6: Characterization of end-to-end phage dimers. G5-pIII phage,
LoopXa-pIII phage, Factor Xa, and SrtAaureus were incubated at room temperature
for 60hrs and purified by PEG8000/NaCl (see Methods section for details). The
resulting product was visualized by atomic force microscopy (a) and dynamic light
scattering with and without reducing agents (b).
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motif as we attach two moieties that cannot be genetically encoded: the fluorophore
TAMRA and pentameric protein CtxB. For proteins, our sortase labeling method
confers the advantage of properly folding the protein separate from the environment
of the phage assembly, which is unavoidable in both phagemid and phage vector
display.
Phage has been used as a nucelophile in sortase reactions [52], but the loop
architecture extends the range of objects that can be attached using sortase. Proteins
requiring their C-termini to be exposed for activity can now be displayed. Targeting
motifs such as those for the endoplasmic reticulum and peroxisomes, which require
the exposure of their C-terminus [90, 93], can remain exposed when displayed on the
phage.
The loop architecture is a framework for screening C-terminal peptide libraries.
We believe these libraries can be useful in the investigation of PDZ domain interac-
tions, which are more prevalent at the C-terminus of proteins [94]. Currently, T7
phage display is commonly used to probe these interactions [95], but with 415 copies
of the modified protein per particle, high avidity interactions are identified. A C-
terminal peptide library on pIII would have only 5 copies and higher affinity peptide
targets could be identified. Although cysteine constrained libraries are available, the
loop architecture can accommodate larger insertions and the protease site allows for
the display of a C-terminus.
The architecture also provides a release mechanism through the disulfide bond.
This feature could be advantageous for the delivery of cargo to cells. Phage has been
used for delivery and can be internalized into mammalian cells [96]. Once inside the
cell, the reducing environment breaks the disulfide bridge in the loop and release
cargo that was attached using the sortase motif. This release event may be critical to
avoiding trafficking and the digestion of cargo in the lysosomes where the phage has
been observed to traffic [97]. Beyond delivery of cargo, the disulfide bond provides
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G5-pIII phageLoopXa-pIII phage
LoopXa-pIII phage + SrtAaureusLoopXa-pIII phage + G5-pIII phage
Figure 3.7: Characterization of end-to-end phage dimers by AFM. LoopXa-
pIII phage and G5-pIII phage were incubated with SrtAaureus to form phage dimers.
The LoopXa-pIII phage and G5-pIII phage were visualized individually (top panels).
The two mixed and the LoopXa-pIII phage with SrtAaureus were analyzed by AFM
(bottom panels).
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a system for purification of a ligand from a mixture. A phage displaying a target
of interest, whether by phage display or sortase labeling, can interact with a ligand
in a mixture which can be extracted using PEG8000/NaCl precipitation. Using a
reducing agent, it is possible to separate the ligand from the phage.
Sortase has been used to create novel multi-phage structures [52], and we
demonstrate that the loop architecture with sortase-mediated reactions can be used
to form phage dimers. These connections demonstrate that the sortase-mediated re-
actions can connect two megadalton sized moieties. Previously, these end-to-end link-
ages have been made using ordered phage at high concentrations, biotin-streptavidin,
or leucine zippers [7, 98, 99]. Compared to the first, our method can produce dimers
at phage concentrations an order of magnitude lower and provide more permanent
linkages. For the second, the leucine zippers are expressed using the phagemid which
can be low in efficiency compared with phage vector display used in our method.
For biotin-streptavidin linkages, the multivalency of streptavidin can lead to
node structures forming branched networks that make it difficult to pattern materials
in a linear fashion. Because multiple pIII proteins are present on a single phage, mul-
tiple linkages are possible using sortase-mediate reactions, but none were observed
when forming our linkages. We attribute this 1-to-1 stoichiometry to the steric hin-
drance provided by one phage once it has been attached. Our method also removes
the addition of a tetrameric streptavidin protein, which creates space between the
linked phages and consequently the space between the nucleated materials. Given
the space between them acts as an insulator, the reduction of this space is critical for
conductance properties in the building of biotemplated nanowires.
While C-terminal display has been achieved previously with phagemid display,
the ability to expose a C-terminus in phage vector display allows for a more homoge-
nous display across a phage population, which makes it more ideal for peptide library
display. With this framework, we demonstrate the ability to functionalize the loop
57
through sortase-mediated reactions and link an entire phage to form dimer structures.
We envision the architecture described in this work will increase the range of objects
that can be displayed on M13 as well as improve the ability to create C-terminal
display libraries.
3.4 Methods
C-terminal phage vector display
The DNA oligonucleotides used for phage engineering are shown in Supplemen-
tary Table A.2. Using the Quik Lightning Site-Directed Mutagenesis Kit (Stratagene),
silent mutations were inserted into the 983 vector (Ghosh, D. et al., unpublished) at
the C-termini of pIII, pVI, and pIX. The starting vector contained the biotin accep-
tor peptide (GLQDIFEAQKIEWHE) fused to the N-terminus of pIX, DSPHTELP
on N-terminus of pVIII and SPARC (secreted protein, acidic and rich in cysteine)
binding peptide (SPPTGINGGG) on the N-terminus of pIII. For the pIII, cut sites
for BspEI and BclI were introduced using pIIIBspEIBclITop and pIIIBspEIBclIBot-
tom oligonucleotides. For pVI, an AatII cut site was introduced using pVIAatIITop
and pVIAatIIBottom oligonucleotides and the AgeI cut site was introduced using the
oligonucleotide pair pVIAgeITop and pVIAgeIBottom. For pIX, a BspHI site existed
previously in the genome and a SpeI cut site was introduced using the pIXSpeITop
and pIXSpeIBottom oligonucleotide pair.
For pIII C-terminal display, the vector was digested with BspEI and BclI.
Three pairs of annealed oligos: pIIILPETGGHA-C and pIIILPETGGHA-NC, pIII
1GLPETGGHA-C and pIII1GLPETGGHA-NC, and pIII3GLPETGGHA-C and pIII
3GLPETGGHA-NC were annealed and inserted into the digested vector. To de-
termine whether the insert had been incorporated into the phage genome, PCR
reactions were performed on the ligations using the coding primer from the inser-
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tion (pIIILPETGGHA-C, pIII1GLPETGGHA-C, and pIII3GLPETGGHA-C) and
pVISeq as primers. The PCR reactions were analyzed by agarose gel stained with
SYBR Safe Stain (Life Technologies) and visualized using a Gel Doc 2000 Gel Doc-
umentation System (BioRad). The same procedure was performed for pVI and pIX
C-terminal insertions using their respective enzymes and insertion oligos. pVI PCR
reactions used the non-coding strand from the insertion with pIIIBspEIBclITop as
primers. The pIX PCR reactions used the coding strand of the insertion and -96gIII
as primers.
The ligation reactions were transformed into the XL-1 Blue bacterial strain,
plated in agar top on LB agar plates containing 1mM IPTG, 40µg/mL X-Gal, and
30µg/mL tetracycline. Plaques were selected and DNA was isolated and sequenced
to check for the insertion.
Construction and amplification of LoopXa-pIII phage
The oligonucleotides used in engineering the LoopXa-pIII phage are shown in
Supplementary Table A.2. Phage containing the loop with a trypsin cut site was con-
structed from an M13KE vector (New England Biolabs). The vector was digested with
Acc65I and EagI. The annealed oligonucleotides pIIILoop-C and pIIILoop-NC were
annealed and ligated into the digested vector. The Loop-pIII phage was converted
to LoopXa-pIII phage by mutagenesis using the Quik II Site-Directed Mutagenesis
kit (Stratagene) with oligonucleotides pIIILoopXaTop and pIIILoopXaBottom. The
phage vectors were plated as described in C-terminal phage vector display section.
For LoopXa-pIII phage amplification, the E. coli strain ER2738 (New England
Biolabs) in LB media supplemented with 30µg/mL tetracycline, was infected with
phage for at least 12hrs at 37◦C. The cultures were centrifuged at 12000g for 20min
to remove bacteria and the phage was precipitated overnight from the supernatant
at 4◦C with the addition of 1/5 of the supernatant volume of 20% PEG8000/2.5M
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NaCl solution. Upon centrifugation at 13500g for 20min, the pellet was resuspended
in 25mM Tris, 150mM NaCl, pH. 7.0-7.4 (TBS). For further purification, this re-
suspension was subjected to two rounds of centrifugation/precipitation. The final
phage concentration averaged between 1013-1014 plaque forming units (pfu) per mL
as determined by UV-vis spectrometry [76].
Sortase-mediated reactions
Sortase reactions were performed as indicated in the figures. A typical sor-
tase reaction for labeling LoopXa-pIII phage involved 160nM phage, 30µM SrtAaureus,
230nM Factor Xa, 100µM nucleophile incubated for 5hrs at room temperature. The
concentration reported for G3-CtxB is the monomer concentration. The sortase la-
beling reactions with GGGK(TAMRA) were monitored by SDS-PAGE under reduc-
ing and non-reducing conditions followed by fluorescent imaging and staining with
Coomassie. For the CtxB labeling reactions, the reactions were analyzed by SDS-
PAGE in reducing and non-reducing conditions followed by immunoblot using an
anti-pIII antibody (New England Biolabs) and anti-CtxB (GenWay Biotech).
For the end-to-end structures, 120nM LoopXa-pIII phage, 180nM G5-pIII
phage, 230nM Factor Xa, 30µM SrtAaureus, and 10mM CaCl2 in TBS incubated for
60hrs at room temperature. The reaction was diluted in TBS such that the LoopXa-
pIII concentration was below 10nM and purified by PEG8000/NaCl precipitation.
After removing the supernatant, the reaction was resuspended in water.
Atomic Force Microscopy (AFM)
Phage preparations were diluted in water to a concentration of 2x1011 pfu/mL.
100µL of the phage solution was deposited on a freshly cleaved mica disc. AFM images
were taken on a Nanoscope IV (Digital Instruments) in air using tapping mode. The
tips had spring constants of 20-100N/m driven near their resonant frequency of 200-
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400kHz (MikroMasch). Scan rates were approximately 1Hz. Images were leveled
using a first-order plane fit to remove sample tilt.
Dynamic Light Scattering (DLS)
DLS measurements were obtained with a DynaPro NanoStar (Wyatt Tech-
nology). Phage mixtures were diluted to ∼1012 pfu/mL in water. Samples under
reducing conditions contained 0.1M DTT. 8µL of the samples was loaded into a mi-
crocuvette. Samples from each experiment were measured 25 times and the results
were averaged by cumulant analysis. Autocorrelation functions were used as a di-
rect comparison of linkages because multi-phage structures have a slower Brownian
motion causing the signal correlation to be delayed to longer relaxation times.
Miscellaneous
Expression and purification of SrtAaureus and G3-CtxB were performed as de-
scribed [47]. The sortase reactions were analyzed on 10% Laemlli SDS-PAGE gels.
The GGGK(TAMRA) peptide was obtained from the Swanson Biotechnology Cen-
ter. For mass spectrometry, the protein bands of interest were excised, subjected to
protease digestion, and analyzed by electrospray ionization tandem mass spectrom-
etry (MS/MS). Fluorescent gel images were obtained using a variable mode imager
(Typhoon 9200; GE Healthcare).
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Chapter 4
Formation of phage networks using
DNA hybridization
4.1 Introduction
The ordering of materials at the nanoscale level is a significant challenge. The
properties of the material and their interactions with other materials are sensitive to
their patterning and orientation. This patterning is important for the construction
of electronic [100], optical [101, 102], and plasmonic devices [103, 104]. Current high
throughput lithography techniques can generate features at the tens of nanometers
scale (∼30nm) [105], but it is difficult to generate these patterns over large areas
[106]. To achieve the desired organization of material on larger areas, a self assembly
approach is necessary to generate such high resolution organization.
DNA hybridization is a crosslinking method that can self assemble these
nanoscale features and has been used to produce nanostructures [13]. Unpaired single
stranded DNA (ssDNA) functions as a flexible linker to control the spacing between
the materials. The specific hybridizing sequence between strands can be tuned to
impart specificity and alter the melting temperature. These connections also pro-
vide versatility as DNA hybridization is reversible under heating and cooling. DNA
crosslinking has been used to order spherical nanoparticles [107, 108] and icosahedral
viruses [109] into crystallized lattices, while changes to the hybridizing sequence alter
the packing of the particles [110, 111].
M13 bacteriophage is a material scaffold, which has been used as a scaffold
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for the nucleation of materials to form nanowires [28, 35, 36]. It has a cylindrical
shape 880nm long and 6nm in diameter which creates a high surface area to volume
ratio, a desirable trait for nucleating materials. The phage is composed of five capsid
proteins with 5 copies of pIII and pVI located at one end and 5 copies of pVII and
pIX located at the other. The body is composed of 2700 copies of pVIII. These five
M13 capsid proteins can be genetically modified through a process known as phage
display [53, 54]. Using phage display of peptide libraries, peptides have been identified
that when expressed on phage can bind materials including plasmonic materials like
gold and silver [28, 35] as well as carbon nanotubes [30, 38].
The multiple capsid proteins of phage provide three distinct motifs for attach-
ment: the body and both ends. By controllably connecting the phage, materials can
be connected at the nanoscale. Previous work to create ordered phage used high
concentrations of phage to form liquid crystals [98], which can be crosslinked to form
fibers [112]. When phage is at lower concentrations, phage form unordered but porous
hydrogels (Burpo, F. J. et al., unpublished). In the formation of fibers and hydro-
gels, gluteraldehyde is used to crosslink the exposed primary amines of the phage
capsid proteins. This crosslinking method, however, is permanent and not specific to
a particular capsid protein and any functionality that has been added to the pVIII
or other capsid proteins may be hindered or eliminated. In these structures, there
is no separation between the crosslinked phage. DNA hybridization offers advan-
tages over these crosslinking chemistries with specificity, reversibility, and flexibility
in the connections. Combining these materials, we can build DNA crosslinked phage
networks.
In order to build such networks, a conjugation chemistry specific to a single
capsid protein is required to attach DNA. In our network, we aimed to connect the
pVIII of two phages to allow for possible side-by-side alignment of the phage (Fig.
4.1). The connection must be capsid protein specific as other connections can cause
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irregular spacing as a result of disoriented phage. Therefore, chemistries not specific to
a single capsid protein, such as EDC, are not ideal for attaching the DNA to phage to
build these structures. Although the pVIII has been site-specifically biotinylated [52],
streptavidin-biotin linkages are not ideal for attaching DNA since the streptavidin
tetramer is denatured upon heating, which limits the recyclability of the linkages.
Sortase A from Streptococcus pyogenes (SrtApyogenes) has been used to label a
pVIII protein with an N-terminal double alanine motif [52]. The enzyme recognizes
an LPXTA peptide motif and cleaves after the threonine forming an acyl-intermediate
that is resolved by nucelophilic attack by an N-terminal polyalanine motif [45]. Using
this enzymatic labeling technique and a DNA peptide conjugate, we can covalently
attach DNA to the pVIII protein.
We crosslink DNA labeled phage with base pair hybridization and demon-
strate that these structures can be dispersed by heat and reformed upon cooling
below the calculated melting temperature of the crosslinking oligonucleotides. This
initial demonstration that DNA crosslinked phage structures are possible lays the
groundwork for creating recyclable phage networks and combining phage and DNA
nanotechnologies.
4.2 Results
4.2.1 Attaching DNA to pVIII using sortase-mediated reac-
tions
To label phage with DNA, we created a substrate for SrtApyogenes that con-
tains both DNA and the LPETAA substrate motif. We selected DNA oligonucleotides
(DNA A and DNA B), shown in Table 4.1, which had been used to order gold nanopar-
ticles [107]. The oligonucleotides contain 15bp complementary regions at their 5’ ends.
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At the 3’ end, there is a 35bp ssDNA linker, whose length was found to be critical for
achieving crystallization of the nanoparticles [107]. A thiol group was installed at the
3’ end for chemical conjugation. We attached the DNA to an L(maleimide)-PETAA
peptide and purified the reaction by size exclusion chromatography. We monitored the
conjugation reaction by MALDI-TOF mass spectrometry (Fig. 4.2). For both DNA
oligonucleotides, we observed a 700Da shift in molecular weight when the peptide is
reacted with the DNA. This product is consistent with the size of the DNA-LPETAA
fusion. The conjugation reaction went to completion as the peak corresponding to
unreacted DNA is not observed after the reaction with the peptide. No peak was
observed at 700Da corresponding to free peptide (data not shown).
Table 4.1: Oligonucleotides for crosslinking phage
Name Sequence (5’-3’)
DNA A TACTTCCAATCCAATTCTTGTGTCGATAGGTCGGTTGCTTTTTTTTTTTT
DNA B ATTGGATTGGAAGTATCTTGTGTCGATAGGTCGGTTGCTTTTTTTTTTTT
SrtApyogenes requires its nucelophile to have an N-terminal double alanine se-
quence [45]. Therefore, the pVIII, which includes an N-terminal alanine that cannot
be removed, was modified to display two N-terminal alanines (A2-pVIII phage). This
phage was incubated with SrtApyogenes, and DNA A-LPETAA or DNA B-LPETAA.
We purified the reaction using PEG8000/NaCl precipitation to remove excess DNA-
peptide and SrtApyogenes. Removing free DNA-peptide is necessary as it can hybridize
with DNA on the surface of phage labeled with the complementary strand, and thus
block sites for crosslinking.
We analyzed the reactions under reducing conditions on an SDS-PAGE gel
followed by staining with SYBR Gold, a DNA intercalating dye (Fig. 4.3). When the
DNA-peptide, phage, and SrtApyogenes were incubated at 37
◦C, we detected a 25kDa
DNA containing species consistent with the size of the DNA-pVIII. When the gel was
subsequently stained with Coomassie (Fig. 4.3), a 25kDa polypeptide was observed
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ATTGGATTGGAAGTATAACCTAACCTTCAT
Tm=34ₒC
Figure 4.1: Schematic of phage crosslinking by DNA hybridization. The
pVIII proteins of different phage are labeled complementary strands of ssDNA. Hy-
bridization of the DNA strands form linkages between the body of two phage.
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that coincides with the SYBR Gold reactive species supporting the presence of a DNA
protein conjugate. We confirmed by mass spectrometry that this species contained
part of the pVIII protein for reaction for both DNA A and DNA B (Fig. 4.4). In
the samples that were purified by PEG/NaCl precipitation, we did not detect the
free DNA-peptide and SrtApyogenes-DNA intermediate showing our purification was
successful. Although the pVIII protein showed staining, this staining was not specific
and present even when DNA-peptide conjugate was not present.
4.2.2 Crosslinking phage using DNA hybridization
Although the calculated melting temperature of the oligonucleotides is 34◦C,
the avidity of having multiple copies of the DNA may increase the melting temper-
ature between the crosslinked phages making it impossible to break up the phage
aggregates without going to high temperatures. To produce phage which would
have less avidity effects in its crosslinking, we performed a second labeling reaction
with 5-fold lower concentration of the DNA-peptide. The reaction was purified by
PEG8000/NaCl purification and analyzed the reactions by SDS-PAGE and stained
the gel with SYBR Gold (data not shown). Compared with our initial labeling, we
observed less DNA-pVIII for both DNA A and DNA B labeling.
In order to crosslink the phage, the labeled phage was subjected to the an-
nealing process used to hybridize complementary DNA strands. Phage labeled with
DNA A (Phage A) and phage labeled with DNA B (Phage B) as well as the phage
with less DNA labeling (Phage A-less and Phage B-less) were mixed in a 1:1 ratio and
heated to 95◦C and cooled to room temperature. We positively stained the samples
and visualized them by transmission electron microscopy (TEM) (Fig. 4.5a). When
Phage A and Phage B (Phage AB) were annealed, we observed crosslinking of the
phage and the formation of networks comprised of overlapping phage. When the
Phage A-less and Phage B-less were annealed (Phage AB-less), phage connections
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Figure 4.2: MALDI-TOF mass spectrometry of DNA-peptide conjugate.
Thiolated DNA A and DNA B were incubated with L(maleimide)-PETAA to form
DNA-peptides. The reactions were monitored by MALDI-TOF mass spectrometry.
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Figure 4.3: Labeling of pVIII with DNA. A2-pVIII phage was incubated with
SrtApyogenes and DNA A-LPETAA (left panel) and DNA B-LPETAA (right panel) at
37C for 2hrs. The reactions were monitored by SDS-PAGE under reducing conditions.
The gel was stained with SYBR Gold (top panels) and Coomassie (bottom panels).
The molecular weight markers are indicated on the left.
69
were seen, but the network of phage was not as dense (Fig. 4.5a). We did not observe
phage networks by TEM when unlabeled phage, Phage A, and Phage B were heated
and cooled (Fig. 4.5a).
We analyzed the phage networks using dynamic light scattering (DLS) to mon-
itor the size of these phage networks (Fig. 4.5b). The crosslinked structures had an
increase in hydrodynamic radius when compared to individual phage (Table 4.2).
When the phage were annealed together, we saw a population in the hydrodynamic
radius intensity distribution with a radius exceeding 10000nm representing the exis-
tence of large crosslinked structures (Fig. 4.5b). We did not observe this population
in the intensity distributions of the unlabeled phage, Phage A, and Phage B.
Table 4.2: Hydrodynamic radius of phage networks
Sample Hydrodynamic
radius (nm)
Unlabeled Phage 336.345
Phage A 348.408
Phage B 367.029
Phage AB 602.151
Phage AB-less 569.332
4.2.3 Recyclability of phage crosslinking
An advantage of using DNA crosslinking is that the process is recyclable when
the structures are heated and cooled. To demonstrate this feature, we heated and
cooled the phage networks and monitored their structures by DLS (Fig. 4.6a). The
samples were heated to 90◦C before being cooled slowly to 20◦C. During this cycle,
we measured the hydrodynamic radius (Table ??) and intensity distribution at the
temperatures indicated (Fig. 4.6). Upon heating both Phage AB and Phage AB-less
above 80◦C, the population with hydrodynamic radii greater than 10000nm disap-
peared representing the dispersal of the phage networks. The intensity distribution
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Figure 4.4: Characterization of DNA-pVIII fusion proteins by mass spec-
trometry. The DNA-polypeptide corresponding to DNA A-pVIII and DNA B-pVIII
was excised from the SDS-PAGE gel and digested with chymotrypsin. The result-
ing peptides were analyzed by liquid chromatography MS/MS. Peptides positively
identified by sequence are highlighted in yellow.
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and hydrodynamic radius were consistent with phage that was not crosslinked.
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Figure 4.5: DNA hybridized phage networks. Phage A and Phage B as well
as Phage A-less and Phage B-less were mixed and annealed (see Methods section for
details) to form phage networks. The samples were analyzed by transmission electron
microscopy (a) and dynamic light scattering (b).
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Upon cooling to 20◦C, we observed that the population with hydrodynamic
radii greater than 10000nm returned (Fig. 4.6a) and the hydrodynamic radius in-
creases (Table ??). For Phage AB, we saw the large radii population returning at
32.0◦C. For Phage AB-less, crosslinking returned at 21.4◦C. This observation supports
that the number of DNA displayed on the phage affects the annealing temperature
of the crosslinking. When unlabeled phage, Phage A, and Phage B were heated
and cooled, we did not observe any changes in the hydrodynamic radius or intensity
distribution (Fig. 4.7).
After cooling, we collected Phage AB and Phage AB-less and visualized the
samples by TEM after positive staining (Fig. 4.6b). We saw phage networks in both
samples (Fig. 4.6b) demonstrating the recyclability of the phage crosslinking by DNA
hybridization. We noticed less dense crosslinking than that found in Phage AB and
Phage AB-less before DLS analysis. We accounted for this decrease as the samples
were diluted before DLS analysis to not saturate the signal, and the second annealing
cycle was performed at a lower phage concentration than the initial annealing.
4.3 Discussion
Using phage displaying complementary DNA strands, we created networks of
crosslinked phage which we monitored by TEM and DLS. These networks were dis-
persed by heat and reformed upon cooling. The reformation of the networks did
not occur until the temperature had been lowered beneath the calculated melting
temperature of the hybridizing oligonucleotides (Tm=34
◦C), which supports that hy-
bridization is involved in these interactions. Furthermore, we performed the crosslink-
ing using phage displaying different amounts of DNA. The crosslinking returned at
a higher temperature for the phage with more copies of the DNA. These observa-
tions demonstrate that annealing properties can be altered by the number of DNA
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Figure 4.6: Recyclability of phage networks. Phage AB and Phage AB-less,
which formed networks, were heated and cooled. The samples were monitored by
dynamic light scattering (a) and measurements were made at the temperatures indi-
cated. After cooling, the samples were positively stained and visualized by transmis-
sion electron microscopy (b).
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Figure 4.7: Heating and cooling of phage labeled with DNA. Phage, Phage A,
and Phage B were heated and cooled. The samples were monitored by dynamic light
scattering and measurements were made at the temperatures indicated.
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molecules displayed on phage.
These experiments serve as proof that we can use hybridized DNA to produce
multi-phage structures, which may be used for the deposition of materials. The phage
networks formed in this work require optimization to obtain crystalline patterning of
the phage, but this is an initial step to construct an ordered array of nanorods. This
ordering may be achieved by a combination of optimizing the melting temperature
of the hybridized DNA, increasing the phage concentration to the point where phage
can form ordered liquid crystals [98, 112], or using a pre-patterned scaffold to align
DNA labeled phage and fill in the spaces with phage displaying complementary DNA
to create patterned and aligned phage.
These aligned phage materials have specific applications in the construction of
plasmonic devices with optical and biosensor applications [113–115]. Plasmons are the
product of free electron oscillations in a conducting material. When these electrons
are subjected to an external electric field such as that from incident light, electrons
shift in the material to cancel out the electric field. Once the field is removed, the
electrons begin oscillating at the plasma frequency of the material. This phenomenon
has optical implications as light below the plasma frequency are reflected, while light
above the frequency is transmitted. These optical properties are highly sensitive to
the dielectric environment, which makes these materials valuable sensors of binding
events that alter the dielectric constant. In addition to biosensing, the absorption
properties of these materials can be used to construct thinner solar cells [116]. In
these devices, spacing is critical as if the particles were to be in contact, the electron
oscillations would flow between the materials mitigating the plasmonic effects.
Without ordering, these recyclable networks have applications as filtration
meshes. Using phage display, the pVIII of the phage can be engineered with the abil-
ity to bind and trap contaminants. The length of the crosslinking DNA can alter the
melting temperature as well as the size of the pores in the mesh by changing the sepa-
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ration between linked phage. Using heat, the meshes are dispersed and contaminants
are released with temporary denaturing of the pVIII by temperature increase. Cooling
of these phages would reform the mesh with the filtered contaminants removed.
The crosslinking of phage using DNA hybridization can be extended to other
phage to phage linkages including self-assembly of multi-phage nanorods composed of
any number of different phages. Different DNA sequences provide an endless supply
of orthogonal chemistries which can be used to construct multimer connections in a
specific order as programmed into the DNA sequences, which has been used to build
molecular wires [117]. This specificity allows the multi-phage structures to be built in
one reaction instead of building the structures step by step. The specific hybridizing
sequences can be designed with different melting temperatures making it possible to
break the structure sequentially by heating. It may also be possible to build multi-
way junctions between phage using more complex DNA interactions such as Holliday
junctions. This can even be extended into the construction of DNA origami structures
spanning the space between phage. These DNA higher order structures can increase
the rigidity of the linkages or add additional functionality.
DNA has been used in a wide range of technologies including biosensor and
material applications [12, 118]. Using sortase-mediated reactions, we can combine
these technologies with those already developed on phage. In the merging of DNA and
phage nanotechnologies, phage provides a stiffer scaffold given its persistence length is
greater than that of double stranded DNA [119]. To construct more complex devices,
multiple functionalities may need to be placed on a single material scaffold, which is
addressed by the multiple capsid proteins on M13 phage. The protein scaffold of phage
provides a variety of amino acids greater than that of oligonucleotides, supplying more
targets for chemical modification.
Combining the two biomaterials, a single phage can be designed with two
functionalities using DNA aptamers as the addition of the DNA to pVIII does not
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disrupt functionality engineered into the N-terminus of the pVIII protein. Instead
of the hybridizing nucleotides that we added, a DNA aptamer selected for binding
properties can be attached to give a second binding motif. This DNA may make the
phage capable of binding two moieties that require each other for full function. Given
short DNA structures have been used as switches induced by chemical or pH change
[14, 120], it may be possible to have the second binding controlled by environmental
factors.
This work serves as a proof-of-concept that DNA can be displayed on the sur-
face of phage in a site-specific manner, and that the DNA maintains its hybridizing
properties in the formation of networks with recyclable connections. We view these
linkages as initial steps to building higher ordered structures for plasmonic applica-
tions, and we believe this labeling strategy provides a clear bridge between DNA and
phage nanotechnology.
4.4 Methods
DNA-peptide conjugation
The crosslinking DNA, shown in Table 4.1, contained a disulfide group at
their 3’ ends. The thiol group on the DNA was activated overnight in 0.1M DTT
in PBS at 37◦C. The DNA was then purified from excess DTT on a NAP5 column
(GE Healthcare) and eluted in water. The solution was dried and resuspended in
PBS, pH 7.0-7.5. L(maleimide)-PETAA peptide in PBS was added in 2:1 molar
excess of the activated DNA and reacted for 5hrs at 37◦C. In order to deactivate the
excess maleimide, 0.1M DTT was added to the mixture and incubated at 37◦C for
15min. The excess DTT was removed by purifying the reaction on a NAP5 column.
The DNA peptide was dried under vacuum and resuspended in 25mM Tris, pH 7.0-
7.4, and 150mM NaCl (TBS). Before drying by vacuum, samples were collected for
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analysis by MALDI-TOF mass spectrometry. The concentration of the DNA-peptide
was determined by UV-vis spectrometry using the absorbance at 260nm.
Phage Engineering
A2-pVIII phage was modified from an M13SK vector [23] that contained a
DSPHTELP sequence on its pVIII and biotin acceptor peptide (GLQDIFEAQKIE-
WHE) on the pIII. The N-terminus of pVIII was modified using AADSPH-pVIII-
Top and AADSPH-pVIII-Bottom, shown in Supplementary Table A.1 using the
QuikChange II site-directed mutagenesis kit (Stratagene). The generated phage vec-
tor was transformed into the XL-1 Blue bacterial strain and plated in agar top on
LB agar plates containing 1mM IPTG, 40µg/mL X-Gal, and 30µg/mL tetracycline.
Plaques were selected and DNA was isolated and sequenced to check for the modifi-
cation.
For phage amplification, the E. coli strain ER2738 (New England Biolabs)
in LB media supplemented with 30µg/mL tetracycline, was infected with phage for
at least 12hrs at 37◦C. The cultures were centrifuged at 12000g for 20min and the
phage was precipitated from the supernatant at 4◦C with the addition of 1/5 of the
supernatant volume of 20% PEG8000/2.5M NaCl solution. Upon centrifugation at
13500g for 20min, the pellet was resuspended in TBS. For further purification, this
resuspension was subjected to two rounds of centrifugation/precipitation. The final
phage concentration averaged between 1013-1014 plaque forming units (pfu) per mL
as determined by UV-vis spectrometry [76].
Sortase-mediated reactions
Sortase reactions were performed as indicated in the figures. A typical sortase
reaction includes 180nM A2-pVIII phage, 30µM SrtApyogenes, 20µM DNA A-LPETAA
or DNA B-LPETAA incubated in TBS for 2hrs at 37◦C. For Phage A-less and Phage
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B-less, the reaction included only 4µM DNA-LPETAA. The reactions were diluted
in TBS such that the concentration of DNA-LPETAA was under 600nM. For purifi-
cation, the phage was precipitated using PEG/NaCl on ice for at least 3hrs. Upon
centrifugation at 17000g for 15min, the pellet was resuspended in water. The reactions
were analyzed on an SDS-PAGE gel under reducing conditions. The proteins were
fixed to the gel followed by rinsing for 3hrs in water before staining with SYBR-Gold
(Life Technologies) and Coomassie.
Dynamic Light Scattering (DLS)
In order to form the phage networks, Phage A and Phage B were mixed in a
1:1 ratio in 12µL of water at a concentration of 5x1013 pfu/mL. The mixture is heated
to 95◦C for 2min and cooled to 25◦C at a rate of 0.1◦C/s. DLS measurements were
obtained with a DynaPro NanoStar (Wyatt Technology). These annealed mixtures
were diluted to 2x1012 pfu/mL in water and 4µL was loaded into a quartz microcu-
vette. The samples were measured at 25◦C before being heated to 90◦C for 5min after
which the samples were cooled to 20◦C at a rate of 6◦C/min. Each measurement was
made ten times and averaged by cumulant analysis. Intensity distributions of the
hydrodynamic radius were used to monitor crosslinking and the presence of objects
with an increased radius compared to single phage.
Transmission Electron Microscopy (TEM)
TEM measurements were obtained using a JEOL 200Cx TEM (JEOL, Ltd) op-
erating at 120kV. Samples were diluted in water to a concentration of 1x1013 pfu/mL.
5µL of each solution was placed onto a carbon coated 300 mesh copper grid (Electron
Microscopy Sciences). After 60s, the remaining liquid was wicked off and the sample
was stained with 0.5% uranyl acetate (Electron Microscopy Sciences) in water. Due
to the high affinity of phage for metal ions, the samples were positively stained.
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Miscellaneous
Expression and purification of SrtApyogenes were performed as described [47].
The sortase reactions were analyzed on 4-12% Bis-Tris SDS-PAGE gels (Life Tech-
nologies) with MES running buffer. Fluorescent gel images were collected on an Al-
phaImager 2200 (Alpha Innotech). MALDI-TOF mass spectrometry of DNA-peptide
conjugates was performed by the Swanson Biotechnology Center. The L(maleimide)-
PETAA peptide was obtained from the Swanson Biotechnology Center.
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Appendix A
Supplementary Material
GFP-pIII
1 327 655
Protein Coverage:
Sequence MH+ % Mass AA % AAMVSKGEELFTGVVPILVELDGDVNGHK 2882.50 4.10 1 - 27 4.12GEELFTGVVPILVELDGDVNGHK 2437.26 3.47 5 - 27 3.51FSVSGEGEGDATYGK 1503.66 2.14 28 - 42 2.29FSVSGEGEGDATYGKLTLK 1958.97 2.79 28 - 46 2.90FICTTGK 769.39 1.10 47 - 53 1.07LPVPWPTLVTTLTYGVQCFSRYPDHMK 3149.60 4.48 54 - 80 4.12YPDHMKQHDFFK 1592.73 2.27 75 - 86 1.83YPDHMKQHDFFKSAMPEGYVQER 2840.29 4.04 75 - 97 3.51QHDFFK 821.39 1.17 81 - 86 0.92QHDFFKSAMPEGYVQER 2068.95 2.95 81 - 97 2.60QHDFFKSAMPEGYVQERTIFFK 2705.32 3.85 81 - 102 3.36SAMPEGYVQER 1266.58 1.80 87 - 97 1.68SAMPEGYVQERTIFFK 1902.94 2.71 87 - 102 2.44SAMPEGYVQERTIFFKDDGNYK 2595.22 3.69 87 - 108 3.36TIFFKDDGNYK 1347.66 1.92 98 - 108 1.68TIFFKDDGNYKTR 1604.81 2.28 98 - 110 1.98DDGNYKTRAEVK 1395.69 1.99 103 - 114 1.83TRAEVKFEGDTLVNR 1734.91 2.47 109 - 123 2.29AEVKFEGDTLVNR 1477.76 2.10 111 - 123 1.98FEGDTLVNR 1050.52 1.50 115 - 123 1.37FEGDTLVNRIELK 1533.83 2.18 115 - 127 1.98IELKGIDFK 1062.62 1.51 124 - 132 1.37IELKGIDFKEDGNILGHK 2026.10 2.88 124 - 141 2.75GIDFKEDGNILGHK 1542.79 2.20 128 - 141 2.14EDGNILGHK 982.50 1.40 133 - 141 1.37EDGNILGHKLEYNYNSHNVYIMADK 2937.38 4.18 133 - 157 3.82LEYNYNSHNVYIMADK 1973.91 2.81 142 - 157 2.44LEYNYNSHNVYIMADKQK 2230.06 3.17 142 - 159 2.75LEYNYNSHNVYIMADKQKNGIK 2642.30 3.76 142 - 163 3.36QKNGIK 687.41 0.98 158 - 163 0.92NGIKVNFK 919.54 1.31 160 - 167 1.22NGIKVNFKIR 1188.72 1.69 160 - 169 1.53RDHMVLLEFVTAAGITLGMDELYK 2722.39 3.88 216 - 239 3.66DHMVLLEFVTAAGITLGMDELYK 2566.29 3.65 217 - 239 3.51LPETGGGGGSAETVESCLAK 1862.88 2.65 240 - 259 3.05SHTENSFTNVWK 1449.68 2.06 260 - 271 1.83SHTENSFTNVWKDDK 1807.82 2.57 260 - 274 2.29DDKTLDR 862.43 1.23 272 - 278 1.07FRNRQGALTVYTGTVTQGTDPVK 2509.32 3.57 390 - 412 3.51QGALTVYTGTVTQGTDPVK 1936.00 2.76 394 - 412 2.90TYYQYTPVSSK 1336.64 1.90 413 - 423 1.68TYYQYTPVSSKAMYDAYWNGKFR 2839.32 4.04 413 - 435 3.51AMYDAYWNGK 1218.52 1.73 424 - 433 1.53MANANK 648.31 0.92 512 - 517 0.92MANANKGAMTENADENALQSDAKGK 2579.18 3.67 512 - 536 3.82GAMTENADENALQSDAK 1764.77 2.51 518 - 534 2.60GVFAFLLYVATFMYVFSTFANILR 2790.47 3.97 628 - 651 3.66GVFAFLLYVATFMYVFSTFANILRNK 3032.61 4.32 628 - 653 3.97Totals: 21693.28 30.88 199 30.38
Figure A.1: Characterization of the GFP-pIII conjugate by mass spectrom-
etry. The polypeptide corresponding to GFP-pIII was excised from the SDS-PAGE
gel and digested with trypsin. The resulting peptides were analyzed by liquid chro-
matography MS/MS. Peptides positively identified by sequence are highlighted in
yellow and bold.
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GFP-pIX
1 148 296
Protein Coverage:
Sequence MH+ % Mass AA % AAMVSKGEELFTGVVPILVEL 2060.13 6.24 1 - 19 6.42MVSKGEELFTGVVPILVELDG 2232.18 6.76 1 - 21 7.09ELFTGVVPILVEL 1428.83 4.33 7 - 19 4.39DGDVNGHKFSVSGEGEG 1690.73 5.12 20 - 36 5.74DVNGHKFSVSGEGEG 1518.68 4.60 22 - 36 5.07EGEGDATYGKLTLKFI 1741.90 5.28 33 - 48 5.41CFSRYPDHMKQHDFFKSAMP 2472.10 7.49 71 - 90 6.76DHMKQHDFFKSAMP 1718.78 5.21 77 - 90 4.73DFFKSAMPEGYVQ 1518.69 4.60 83 - 95 4.39DFFKSAMPEGYVQERTIFFK 2440.20 7.39 83 - 102 6.76EGYVQERTIFFK 1516.78 4.60 91 - 102 4.05ERTIFFK 940.53 2.85 96 - 102 2.36ERTIFFKDDGNYKTRA 1960.99 5.94 96 - 111 5.41DDGNYKTRA 1039.48 3.15 103 - 111 3.04DDGNYKTRAEVKFEG 1728.82 5.24 103 - 117 5.07DGNYKTRA 924.45 2.80 104 - 111 2.70EVKFEG 708.36 2.15 112 - 117 2.03EGDTLVNRI 1016.54 3.08 116 - 124 3.04EGDTLVNRIELKGI 1556.86 4.72 116 - 129 4.73DTLVNRI 830.47 2.52 118 - 124 2.36DTLVNRIELKGI 1370.80 4.15 118 - 129 4.05DTLVNRIELKGIDFK 1760.99 5.33 118 - 132 5.07DTLVNRIELKGIDFKE 1890.03 5.73 118 - 133 5.41ELKGIDFK 949.54 2.88 125 - 132 2.70EDGNILGHKL 1095.58 3.32 133 - 142 3.38DGNILGHKL 966.54 2.93 134 - 142 3.04DGNILGHKLEYNYNSHNVYIMA 2565.22 7.77 134 - 155 7.43EYNYNSHNVYIMA 1617.70 4.90 143 - 155 4.39DKQKNGIKVNFKIRHNI 2052.18 6.22 156 - 172 5.74DKQKNGIKVNFKIRHNIE 2181.23 6.61 156 - 173 6.08DGSVQLA 689.35 2.09 174 - 180 2.36DGSVQLADHYQQNTPIG 1842.86 5.58 174 - 190 5.74DHYQQNTPIG 1172.53 3.55 181 - 190 3.38DHYQQNTPIGDGPVLLP 1863.92 5.65 181 - 197 5.74DGPVLLP 710.41 2.15 191 - 197 2.36DGPVLLPDNHYLSTQSALSK 2155.10 6.53 191 - 210 6.76DGPVLLPDNHYLSTQSALSKDPN 2481.23 7.52 191 - 213 7.77DNHYLSTQSALSK 1463.71 4.43 198 - 210 4.39DNHYLSTQSALSKDPNEKR 2203.07 6.67 198 - 216 6.42DNHYLSTQSALSKDPNEKRDHMVLL 2911.44 8.82 198 - 222 8.45DPNEKRDHMVLL 1466.74 4.44 211 - 222 4.05DPNEKRDHMVLLEFVTAAGITLGMD 2772.37 8.40 211 - 235 8.45DHMVLLEFVTAAGITLGM 1917.98 5.81 217 - 234 6.08DHMVLLEFVTAAGITLGMD 2033.01 6.16 217 - 235 6.42EFVTAAGITLGMD 1324.65 4.01 223 - 235 4.39EFVTAAGITLGMDELYKLP 2068.07 6.27 223 - 241 6.42DELYKLPETGGGGGYPY 1815.84 5.50 235 - 251 5.74ETGGGGGYPYDVP 1268.54 3.84 242 - 254 4.39DVPDYAQGGQGV 1205.54 3.65 252 - 263 4.05Totals: 17404.73 52.73 155 52.36
Figure A.2: Characterization of the GFP-pIX conjugate by mass spectrom-
etry. The polypeptide corresponding to GFP-pIII was excised from the SDS-PAGE
gel and digested with AspN. The resulting peptides were analyzed by liquid chro-
matography MS/MS. Peptides positively identified by sequence are highlighted in
yellow and bold.
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GFP-pVIII
1 148 296
Protein Coverage:
Sequence MH+ % Mass AA % AAMVSKGEELFTGVVPILVELDGDVNGH 2754.40 8.46 1 - 26 8.78GEELFTGVVPILVELDGDVNGHK 2437.26 7.49 5 - 27 7.77FSVSGEGEGDATYGK 1503.66 4.62 28 - 42 5.07LPVPWPTLVTTL 1336.79 4.11 54 - 65 4.05YPDHMK 790.36 2.43 75 - 80 2.03YPDHMKQHDFFK 1592.73 4.89 75 - 86 4.05DDGNYK 711.29 2.18 104 - 109 2.03AEVKFEGDTLVNR 1477.76 4.54 112 - 124 4.39FEGDTLVNR 1050.52 3.23 116 - 124 3.04GIDFKEDGNILGHK 1542.79 4.74 129 - 142 4.73LEYNYNSH 1039.45 3.19 143 - 150 2.70LEYNYNSHNVYIMADK 1973.91 6.06 143 - 158 5.41YNSHNVYIMADK 1454.67 4.47 147 - 158 4.05YNSHNVYIMADKQK 1710.83 5.25 147 - 160 4.73SHNVYIMADK 1177.57 3.62 149 - 158 3.38NVYIMADKQKNGIKVN 1834.98 5.64 151 - 166 5.41VYIMADKQKNGIKVNFK 1996.10 6.13 152 - 168 5.74TPIGDGPVLLPDNHYLSTQSALSK 2523.31 7.75 188 - 211 8.11HYLSTQSALSK 1234.64 3.79 201 - 211 3.72LPETAAGGGGDPAK 1240.62 3.81 241 - 254 4.73Totals: 14851.19 45.61 137 46.28
Figure A.3: Characterization of the GFP-pVIII conjugate by mass spec-
trometry. The polypeptide corresponding to GFP-pVIII was excised from the SDS-
PAGE gel and digested with trypsin. The resulting peptides were analyzed by liquid
chromatography MS/MS. Peptides positively identified by sequence are highlighted
in yellow and bold.
85
Supplemental Methods
Estimating nearest neighbor packing of GFP on phage surface
Using the crystal structure of the pVIII capsid protein (1IFJ) [121], a model
viral capsid was constructed with five fold symmetry serving as a model of the phage
surface. A crystal structure of GFP (1GFL) [122] was oriented such that its C-
terminus was adjacent to the N-terminus of pVIII. By analyzing this image, it was
determined that one GFP molecule blocked the N-termini of the six pVIII proteins
surrounding the GFP-pVIII fusion meaning at most one out of seven pVIII proteins
can be labeled with a GFP. From this, it was calculated that a single virion with
2700 pVIII proteins would have at most 385 GFP molecules. The visualizations were
performed using WinCoot [123].
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Table A.1: Oligonucleotides for N-terminal phage engineering
Name Sequence (5’-3’)
G5pIIIC GTACCTTTCTATTCTCACTCTGGTGGAGGCGGTGGATC
G5pIIIINC GGCCGATCCACCGCCTCCACCAGAGTGAGAATAGAAAG
A2G4pVIIIC GCTGGCGGGGGAGGG
A2G4pVIIINC GATCCCCTCCCCCGCCAGCTGCA
G5HApIXC CGGCCATGGCGGGCGGAGGTGGAGGCTACCCATACGATG
TTCCAGATTACGCTCAGGG
G5HApIXNC TGAGCGTAATCTGGAACATCGTATGGGTAGCCTCCACCTC
CGCCCGCCATGGCCGGCT
AADSPH-pVIII-Top GTTCCGATGCTGTCTTTCGCTGCTGCAGATTCGCCGCATA
CTGAG
AADSPH-pVIII-Bottom CTCAGTATGCGGCGAATCTGCAGCAGCGAAAGACAGCATC
GGAAC
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Figure A.4: Characterization of the pIII-CtxB conjugate by mass spectrom-
etry. The polypeptide corresponding to pIII-CtxB was excised from the SDS-PAGE
gel and digested with chymotrypsin. Under reducing conditions before digestion, the
pIII-CtxB separates into two portions, which are shown in the two panels. The re-
sulting peptides were analyzed by liquid chromatography MS/MS. Peptides positively
identified by sequence are highlighted in yellow and bold.
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Table A.2: Oligonucleotides for C-terminal phage
engineering
Name Sequence (5’-3’)
pIIIBspEIBclITop CGTTTGCTAACATACTCCGGAATAAGGA
GTCTTGATCATGCCAGTTCTTTTGG
pIIIBspEIBclIBottom CCAAAAGAACTGGCATGATCAAGACTCC
TTATTCCGGAGTATGTTAGCAAACG
pVIAatIITop AGGCTGCTATTTTCATTTTTGACGTCAA
ACAAAAAATCGTTTCTTA
pVIAatIIBottom TAAGAAACGATTTTTTGTTTGACGTCAA
AAATGAAAATAGCAGCCT
pVIAgeITop ATATGGCTGTTTATTTTGTAACCGGTAA
ATTAGGCTCTGGAAAGAC
pVIAgeIBottom GTCTTTCCAGAGCCTAATTTACCGGTTA
CAAAATAAACAGCCATAT
pIXSpeITop TATTTTACCCGTTTAATGGAAACTAGTT
CATGAAAAAGTCTTTAGTCC
pIXSpeIBottom GGACTAAAGACTTTTTCATGAACTAGTT
TCCATTAAACGGGTAAAATA
pIIILPETGGHA-C CCGGAATAAGGAGTCTCTACCGGAAACA
GGAGGCTACCCATACGATGTTCCAGATT
ACGCTT
pIIILPETGGHA-NC GATCAAGCGTAATCTGGAACATCGTATG
GGTAGCCTCCTGTTTCCGGTAGAGACTC
CTTATT
pIII1GLPETGGHA-C CCGGAATAAGGAGTCTGGAGGTGGAAGT
CTACCGGAAACAGGAGGCTACCCATACG
ATGTTCCAGATTACGCTT
pIII1GLPETGGHA-NC GATCAAGCGTAATCTGGAACATCGTATG
GGTAGCCTCCTGTTTCCGGTAGACTTCC
ACCTCCAGACTCCTTATT
pIII3GLPETGGHA-C CCGGAATAAGGAGTCTGGAGGTGGAAGT
GGCGGTGGGAGCGGGGGAGGCTCTCTAC
CGGAAACAGGAGGCTACCCATACGATGT
TCCAGATTACGCTT
pIII3GLPETGGHA-NC GATCAAGCGTAATCTGGAACATCGTATG
GGTAGCCTCCTGTTTCCGGTAGAGAGCC
TCCCCCGCTCCCACCGCCACTTCCACCT
CCAGACTCCTTATT
pVILPETGGHA-C CAAACAAAAAATCGTTTCTTATTTGGATT
GGGATAAACTACCGGAAACAGGAGGCTA
CCCATACGACGTTCCAGATTACGCTTAA
TATGGCTGTTTATTTTGTAA
Continued on next page
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Table A.2 – Continued from previous page
Name Sequence (5’-3’)
pVILPETGGHA-NC CCGGTTACAAAATAAACAGCCATATTAAG
CGTAATCTGGAACGTCGTATGGGTAGCC
TCCTGTTTCCGGTAGTTTATCCCAATCC
AAATAAGAAACGATTTTTTGTTTGACGT
pVI1GLPETGGHA-C CAAACAAAAAATCGTTTCTTATTTGGATT
GGGATAAAGGAGGTGGAAGTCTACCGGA
AACAGGAGGCTACCCATACGACGTTCCA
GATTACGCTTAATATGGCTGTTTATTTT
GTAA
pVI1GLPETGGHA-NC CCGGTTACAAAATAAACAGCCATATTAAG
CGTAATCTGGAACGTCGTATGGGTAGCC
TCCTGTTTCCGGTAGACTTCCACTCCTT
TATCCCAATCCAAATAAGAAACGATTTTT
TGTTTGACGT
pVI3GLPETGGHA-C CAAACAAAAAATCGTTTCTTATTTGGATT
GGGATAAAGGAGGTGGAAGTGGCGGTGG
GAGCGGGGGAGGCTCTCTACCGGAAACA
GGAGGCTACCCATACGACGTTCCAGATT
ACGCTTAATATGGCTGTTTATTTTGTAA
pVI3GLPETGGHA-NC CCGGTTACAAAATAAACAGCCATATTAAG
CGTAATCTGGAACGTCGTATGGGTAGCC
TCCTGTTTCCGGTAGAGAGCCTCCCCCG
CTCCCACCGCCACTTCCACCTCCTTTAT
CCCAATCCAAATAAGAAACGATTTTTTG
TTTGACGT
pIXLPETGGHA-C CTAGTTCTCTCCCGGAAACAGGTGGATAC
CCATACGATGTTCCAGATTACGCTT
pIXLPETGGHA-NC CATGAAGCGTAATCTGGAACATCGTATGG
GTATCCACCTGTTTCCGGGAGAGAA
pIX1GLPETGGHA-C CTAGTTCTGGAGGTGGAAGTCTCCCGGAA
ACAGGTGGATACCCATACGATGTTCCAG
ATTACGCTT
pIX1GLPETGGHA-NC CATGAAGCGTAATCTGGAACATCGTATGG
GTATCCACCTGTTTCCGGGAGACTTCCA
CCTCCAGAA
pIX3GLPETGGHA-C CTAGTTCTGGAGGTGGAAGTGGCGGTGGG
AGCGGGGGAGGCTCTCTCCCGGAAACAGG
TGGATACCCATACGATGTTCCAGATTA
CGCTT
Continued on next page
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Table A.2 – Continued from previous page
Name Sequence (5’-3’)
pIX3GLPETGGHA-NC CATGAAGCGTAATCTGGAACATCGTATGG
GTATCCACCTGTTTCCGGGAGAGAGCCTC
CCCCGCTCCCACCGCCACTTCCACCTC
CAGAA
96gIII CCCTCATAGTTAGCGTAACG
pVISeq GTTGCTATTTTGCACCCAGC
pIIILoop-C GTACCTTTCTATTCTCACTCTGAGCCGT
GGATTCATCATGCACCGCCGGGTTGTGG
GAATGCTCTTCCTGAGACCGGTGGTTAC
CCATACGATGTTCCAGATTACGCTATGA
ATGCTCCAAGATCATCGATGAGTAATAC
TTGCGATGAAAAAACCCAAAGTCTAGGT
GTAAAAGGAGGCGGGTC
pIIILoop-NC GGCCGACCCGCCTCCTTTTACACCTAGA
CTTTGGGTTTTTTCATCGCAAGTATTAC
TCATCGATGATCTTGGAGCATTCATAGC
GTAATCTGGAACATCGTATGGGTAACCA
CCGGTCTCAGGAAGAGCATTCCCACAAC
CCGGCGGTGCATGATGAATCCACGGCTC
AGAGTGAGAATAGAAAG
pIIILoopXaTop GTTCCAGATTACGCTATTGAAGGGAGAT
CATCGATGAATAC
pIIILoopXaBottom GTATTCATCGATGATCTCCCTTCAATAG
CGTAATCTGGAAC
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Appendix B
Constructs and protocols
2.1 Constructs
Table B.1: Phage vectors
Construct pIII pVIII pIX Vector
G5-pIII G5 AEGD - M13KE
A2G4-pVIII - AAGGGG - M13SK
G5HA-pIX SBP ADSPHTELP G5-(HA)-QGGQGVD 983
A2-pVIII G5-pIII G5 AADSPHTELP - M13SK
pIIIpVIpIX-CCut SBP ADSPHTELP (BAP)-GQGGQGVD 983
LoopXa-pIII LoopXa AEGD - M13KE
A2-pVIII BAP AADSPHTELP - M13SK
Note: The sequences listed in the table above represent the N-termini
of the pIII, pVIII, and pIX proteins. For pIII and pIX, the se-
quences are fused to the N-terminus of the mature proteins present in
M13KE. For pVIII, the sequences listed are fused to the following se-
quence: DPAKAAFNSLQASATEYIGYAWAMVVVIVGATIGIKLFKKFTSKAS.
SBP (SPARC binding peptide)= SPPTGINGGG. HA= YPYDVPDYA. BAP (bi-
otin acceptor peptide)= GLQDIFEAQKIEWHE. LoopXa= EPWIHHAPPGCG-
NALPETGGYPYDVPDYAIEGRSSMSNTCDEKTQSLGVKGGG.
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Table B.2: Protein expression vectors.
Protein Antibiotic Inducer
SrtApyogenes Kanamycin IPTG
SrtAaureus Ampicillin IPTG
GFP.LPETG.H6 Kanamycin IPTG
GFP.LPETAA.H6 Kanamycin IPTG
GFP.HAtag.LPETG.H6 Kanamycin IPTG
GFP.HAtag.LPETAA.H6 Kanamycin IPTG
Streptavidin.HAtag.LPETGG.H6 Kanamycin IPTG
G3.CtxB Kanamycin Arabinose
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2.2 Protocols
Amplification Of M13 Phage
Materials
1. E. coli . Strain ER 2738.
2. LB Broth. 25g of LB broth powder per 1L of H2O
3. 1000X tetracycline. 30mg/mL in methanol
4. PEG8000/ NaCl. 150g PEG8000, 110g NaCl in 750mL of H2O
5. TBS. 25mM Tris, 150mM NaCl, pH 7.0-7.4
6. M13 Bacteriophage. ∼1011-1012 pfu/mL
Protocol
Day 0
Note: Small scale amplification amounts are indicated in parentheses.
1. Prepare overnight culture (OC): 20mL LB, 20µL 1000X tetracycline, 1 colony
of E. coli (ER 2738) in sterilized 250 mL flask. Shake at 37◦C overnight (12-16
hrs).
2. Prepare 800mL (25mL) of LB broth in a 2L (250mL) flask.
Day 1
1. Dilute 8mL (200µL) OC with 800µL (20µL) of 1000X tetracycline in each 2L
(250mL) flask with prepared LB broth.
2. Infect bacteria with 70µL (15µL) of 1011-1012 pfu/mL phage solution for the 2L
(250mL) flask.
3. Place flasks in 37◦C incubator for 30min. After incubation, shake at 37◦C for
>12hrs.
4. Pour contents of flask into sterilized centrifuge tubes. Balance tubes with LB,
and spin in table top centrifuge at 12000g for 15min to pellet out bacteria.
5. Mix supernatant with 160mL (5mL) PEG/NaCl. Invert 4-6 times, and store at
4◦C overnight.
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Day 2
1. Spin phage-PEG/NaCl mixture at 13500g for 20min to pellet out phage.
2. Carefully pour out and discard supernatant. Resuspend phage precipitates in
15mL (1mL) of TBS.
3. Transfer resuspended phage from into 50mL (1.5mL) centrifuge tubes. Spin at
12000g at 4◦C for 15min to pellet out bacteria.
4. Pour supernatant into new sterilized centrifuge tubes, taking care not to disrupt
bacterial pellet. 5mL of PEG was added to supernatant. Invert 4-6 times, and
store at 4◦C overnight, or on ice for 2 hrs. (Note: The small scale amplification
is complete at this point and can be stored at 4◦C ).
Day 3
1. Spin phage-PEG/NaCl solution at 13500g for 20min to pellet out phage.
2. Pour out and discard supernatant. Resuspend phage precipitates in 1mL of
TBS.
3. Transfer resuspended phage from the centrifuge tube to a 1.5mL tube.
4. Centrifuge phage solution in microcentrifuge at 10000g for 15min.
5. Transfer supernatant into another clean 1.5mL tube. This final solution should
have a concentration of 1013-1014 pfu/mL.
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Purification of phage sortase reaction
Materials
1. Sortase reaction. 30µL in TBS.
2. PEG8000/NaCl. 150g PEG8000, 110g NaCl in 750mL water
3. TBS. 25mM Tris, 150mM NaCl, pH 7.0-7.4
Protocol
1. Dilute reaction to 1mL in TBS in a 1.5mL eppendorf tube. For reactions greater
than 30µL divide reaction into multiple tubes.
2. Move diluted mixture to another eppendorf containing 250µL of PEG8000/NaCl
solution. Mix well.
3. Incubate mixture on ice for at least 3hrs.
4. Centrifuge sample at 4◦C for 17000g for 20min. Remove supernatant and spin
for an additional minute to remove excess PEG and salt.
5. After removing the supernatant, resuspend the pellet in desired buffer.
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Creating DNA peptide conjugates
Materials
1. DNA-thiol. 100µM in PBS.
2. Maleimide-peptide. 1mM in PBS.
3. Dithiothreitol (DTT). 1M in water
4. NAP5 Column. GE Healthcare
5. TBS. 25mM Tris, 150mM NaCl, pH 7.0-7.4
Protocol
Day 0
1. 50µL of 100µM DNA-thiol is mixed with 5µL of 1M DTT. The mixture is
incubated at 37◦C overnight (>12hrs).
Day 1
1. Equilibrate NAP5 column with 10mL of water. Dilute DTT and DNA mixture
to 500µL in water. Add to column and elute with 1mL of water.
2. Dry 1mL to a pellet by spin vacuum. Resuspend pellet in 50µL of PBS. Mea-
sure concentration of DNA solution using absorbance at 260nm and extinction
coefficient of DNA oligonucleotide.
3. Add maleimide-peptide such that a 2:1 molar ratio of peptide to DNA. Incubate
the mixture at 37◦C for 5hrs.
4. After 5hrs add 5µL of 1M DTT and incubate at 37◦C for 15-30min.
5. Equilibrate a NAP5 column with 10mL of water. Dilute the DNA, peptide, and
DTT mixture in water to 500µL and add to the column. Elute with 1mL of
water.
6. Dry the elution by spin vacuum and resuspend in 50µL of TBS. Store at 4◦C.
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Table B.3: Antibodies for immunoblotting.
Antibody Blocking Buffer Concentration Secondary
anti-pIII Milk 1:8000 anti-mouse-HRP (1:8000)
anti-HA-HRP Milk 1:6000
streptavidin-HRP BSA 1:15000
anti-GFP-HRP Milk 1:10000
anti-CtxB Milk 1:6000 anti-rabbit-HRP (1:6000)
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